[go: up one dir, main page]

TW200900431A - Polyimide film - Google Patents

Polyimide film Download PDF

Info

Publication number
TW200900431A
TW200900431A TW96148315A TW96148315A TW200900431A TW 200900431 A TW200900431 A TW 200900431A TW 96148315 A TW96148315 A TW 96148315A TW 96148315 A TW96148315 A TW 96148315A TW 200900431 A TW200900431 A TW 200900431A
Authority
TW
Taiwan
Prior art keywords
film
fda
tda
solution
bis
Prior art date
Application number
TW96148315A
Other languages
Chinese (zh)
Other versions
TWI376394B (en
Inventor
Hak-Gee Jung
Sang-Wook Park
Hyo-Jun Park
Original Assignee
Kolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020060129005A external-priority patent/KR101142692B1/en
Priority claimed from KR1020060128978A external-priority patent/KR101167337B1/en
Priority claimed from KR1020060129009A external-priority patent/KR101167341B1/en
Priority claimed from KR1020060128992A external-priority patent/KR101211857B1/en
Priority claimed from KR1020060129011A external-priority patent/KR101167483B1/en
Priority claimed from KR1020060128999A external-priority patent/KR101167339B1/en
Application filed by Kolon Inc filed Critical Kolon Inc
Publication of TW200900431A publication Critical patent/TW200900431A/en
Application granted granted Critical
Publication of TWI376394B publication Critical patent/TWI376394B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2379/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
    • C08J2379/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08J2379/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

Disclosed is a polyimide film, which is colorless and transparent and exhibits superior properties, including mechanical properties and heat stability, and thus is usable in various fields, including semiconductor insulating films, TFT-LCD insulating films, transparent electrode films, passivation films, liquid crystal alignment layers, optical communication materials, protective films for solar cells, and flexible display substrates.

Description

200900431 九、發明說明: 【發明所屬之技術領域】 本發明有關於一種無色且透明的聚亞醯胺膜。 【先前技術】 5 大體而言,聚亞醯胺(PI)樹脂係與藉由聚醯胺酸在高溫 下之閉環及脫水反應所得的高耐熱樹脂有關,而聚醯胺酸 係透過芳香族二酸酐與芳香族二胺或芳香族二異氰酸酯的 /谷液聚合反應所獲得。在聚亞酿胺樹脂的製備方面,芳香 族二酸酐包括例如:苯均四酸二酐(PMDA)或聯苯四酸二酐 10 (BPDA);以及芳香族二胺則包括例如:氧化二苯胺(〇DA)、 對-苯二胺(p-PDA)、間-苯二胺(m_PDA)、亞甲基二苯胺 (MDA)及二胺基苯基六氟丙燒(hfda)。 因為不溶、難熔及超高耐熱性之聚亞醯胺樹脂具有包 括耐熱性與耐氧化性,耐輻射性,耐低溫性及耐化學性等 is優異的特性,所以被用於種種不同的領域,包括諸如汽車 材料、航空材料或航太材料之類的先進耐熱材料,與諸如 絕緣塗覆劑、絕緣膜、半導體、或TFT-LCD用電極保護膜 之類的電子材料。近來,聚亞醯胺樹脂已被用來作為顯示 器材料,例如將導電填料與聚合物混合,或將導電填料塗 2〇覆到聚合物薄膜表面上,所構成的光纖或液晶配向層,以 及透明電極膜。 然而,聚亞醯胺樹脂的高芳香環密度與電荷轉移交互 作用使其變成褐色或黃色,以致惱人地減低可見光範圍的 透光率。聚亞醯胺樹脂的黃色或褐色使其難以應用於要求 6 200900431 透明度的領域中。 這㈣題’許多純化單體與高純度溶劑以進行 A '、方去已被實現’但對透光率的改良效果卻不大。 分來第5M朗卜種使㈣雜二酸酐成 刀來取代方香族二酸酐的方法。雖然此法與純化方法相 文。了液相或膜相的透明度與顏色,然而在增進透光 =方面仍妓限,目而纽達成高透鮮的要求,另外, 其熱與機械性質也變差。 10 15 20 在美國專利第4595548號、4603061號、4645824號、 彻5972 说、5218083 號、5093453 號、5218077 號 5367046 號、5338826號、5986〇36號與必⑽號,以及韓國專利 公開第2〇削0〇9437號中贿_製備具新穎結構之聚亞 酸胺’係在熱性質未顯著降低的範圍内改善透光率與顏色 透明度,主要是使用具有諸如_〇_、_8〇2_或CH2_的連結基、 由於不在雜(P_pGSiti〇n)連接而在間位(m_pGsitiGn)連接所 造^的·彎折結構、或是具有如_cf3取代基之芳香族二酸野 和芳香族二胺單體。然而,此種聚魏胺被證實其機械性 質兴色4曰數與可見光透光率方面,均不足以用於半導體 _膜' TFT_IXD絕緣膜、電極護膜及軟性顯示器基板。 【發明内容】 因此,本發明提供一種無色透明且展現出包括機械性 質及熱穩定性等優異性質的聚亞醯胺膜。 依據本發明的較佳實施例,係提供一種以芳香族二酸 7 200900431 肝與芳香族二胺之聚合物所製成的聚亞醯胺膜,以50至 100 μιη的膜厚為基準,使用紫外光分光光度計測量其透光 率’於波長380至780 nm時,具有等於或大於85%的平均 透光率,並具有等於或小於15的黃色指數。 5 依據此實施例之聚亞醯胺膜,以50至1〇〇 μιη的膜厚 為基準,使用紫外光分光光度計測量其透光率,於波長551 至780 nm時,可具有等於或大於88%的平均透光率,於波 長550 nm時,可具有等於或大於88%的透光率,於波長5〇〇 11111時,可具有等於或大於85°/。的透光率,以及於波長42〇 ίο nm時,可具有等於或大於50%的透光率。 依據此貫施例之聚亞酿胺膜’以5〇至1〇〇 μιη的膜厚 為基準,於波長420 nm時,可具有小於50的光學密度。 在依據此實施例的聚亞醯胺膜中,芳香族二酸酐可包 含一種化合物,或是二種或多種化合物的混合物,該化合 I5物係選自2,2-雙(3,4-二羧基苯基)六氟丙烷二酸酐 (2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride, 6_FDA)、4- (2,5-二氧四氫呋喃-3-基)-1,2,3,4-四氫化萘 -1,2- if (4-(2,5-dioxotetrahydrofuran-3-yl)-l,2,3,4- tetrahydronaphthalene-l,2-dicarboxylic anhydride, TDA)以及 2〇 4,4’- (4,4’-異丙烯基二苯氧基)雙(鄰苯二甲酸酐) (4,4,-(4,4,-isopropylidenediphenoxy)bis(phthalic anhydride), HBDA)。 在依據此實施例的聚亞醯胺膜中,芳香族二胺可包含 一種化合物,或是二種或多種化合物的混合物,該化合物 8 200900431 係選自氧化二苯胺(oxydianiline,ODA)、1,3-雙(3-胺基苯 氧基)苯(l,3-bis(3-aminophenoxy)benzene,APB-133)、1,3-雙(4-胺基苯氧基)苯(l,3-bis(4-aminophenoxy)benzene, APB-134) 、1,4-雙 (4-胺基苯氧基)苯 5 (l,4-bis(4_aminophenoxy)benzene,APB-144)、雙(3-胺基苯 基)颯(bis(3-aminophenyl)sulfone,3-DDS)、雙(4-胺基笨 基)石風(bis(4-aminophenyl)sulfone,4-DDS)、2,2’-雙(三氟 曱基)-4,4’-二胺基聯苯(2,2’-1^(1;11£111〇1:〇11^]1>4)-4,4’-diaminobiphenyl, 2,2’-丁卩08)、3,3’-雙(三氟曱基)-4,4,-10 二胺基聯苯(3,3’-bis(trifluoromethyl)-4,4’-diaminobiphenyl, 3,3’-TFDB)、2,2’-雙[4 (4-胺基苯氧基)苯基]六氟丙烷 (2,2,-bis[4(4-aminophenoxy)phenyl]hexafluoropropane,4-BD AF)、2,2’-雙[3 (3-胺基苯氧基)苯基]六氟丙烷 (2,2,-bis[3(3-aminophenoxy)phenyl]hexafluoropropane,3-BD 15 AF)、4,4’-雙(3-胺基苯氡基)二苯基砜 (4,4J-bis(3-aminophenoxy)diphenylsulfone, DBSDA)以及 2,2-雙[4- (4-胺基苯氧基)苯基]丙烷 (2,2-bis[4-(4-aminophenoxy)phenyl]propane,6-HMDA)。 依據第三實施例之聚亞醯胺膜,以50至100 μιη的膜 20厚為基準,於1 GHz時,可具有等於或小於3.0的介電常 數。 依據第三實施例之聚亞醯胺膜,以50至100 μπι的膜 厚為基準,於50至200°C時,可具有等於或小於50 ppm 的平均熱膨脹係數(CTE)。 9 200900431 依據第三實施例之聚亞醯胺膜,以5〇至1〇〇 μιη的膜 厚為基準,可具有等於或大於3 0 Gpa的模數。 依據弟二實施例之聚亞醯胺膜,以50至100 的膜 厚為基準,可具有等於或小於40011111之50%紫外光截止波 5 長(cut off wavelength)。 ^本發明可提供一種無色透明且具有包括機械性質及熱 穩定性等優異性質的聚亞酿胺樹脂,因而可供用於種種不 同的領域,包括半導體絕緣膜、TFT_LCD絕緣膜、鈍化膜、 液晶配向層、光學通訊材料、太陽能電池用保護膜以及軟 10性顯不器基板。本發明另亦提供一種使用該聚亞醯胺樹脂 的液晶配向層與聚亞酿胺膜。 【圖式簡單說明】 第一圖係為範例1之聚亞醯胺膜置於一張紙上的照 15片;以及 第二圖係為比較範例1之聚亞醯胺膜置於一張紙上的 照片。 【實施方式】 兹將本發明詳予說明於後。 本發明的聚亞醯胺膜是一種由二胺與二酸酐之共聚物 所製備之聚亞醯胺樹脂的薄膜,特別是一種無色透明的聚 亞醯胺膜。 本發明所製得之聚亞醯胺膜,以50至1〇〇 μιη的膜厚 200900431 為基準,使用紫外光分光光度計測量其透光率,於波長38〇 至780 nm時,具有等於或大於85%的平均透光率,並~具有 等於或小於15的黃色指數。 、’ 此外’該聚亞醯胺膜以50至100 μιη的膜厚為其準, 5使用紫外光分光光度計測量其透光率,於波長551 ^ 78〇 nm時,較佳可具有等於或大於88%的平均透光率,於波長 550 nm時,較佳可具有等於或大於88%的透光率,於波^ 500 nm時,較佳可具有等於或大於85%的透光率,以及於 波長42〇nm時,較佳可具有等於或大於5〇%的透光率。、 10 符合前述透光率及黃色指數之本發明的聚亞醯胺膜, 可應用於一般習用之黃色的聚亞醯胺膜難以應用、透明度 要求高的領域,包括TFT_LCD的保護臈或是擴散板與^ 層,例如TFT-LCD的夾層(interiayer)、閘極絕緣層(⑽ Insulator)與液晶配向層。當透明的聚亞醯胺應用到液晶配 向層時,有助於增進孔隙率,因而可製造出具有高對比的 TFT-LCD,並且透明的聚亞醯胺亦可用於軟性顯示器基板 (Flexible Display Substrate)。 以50至100 的臈厚為基準,本發明的聚亞醯胺膜 於波長420 nm時,可具有小於5〇的光學密度。符合前述 2〇光學密度與透光率的聚亞醒胺膜,降低了用以表示穿透該 薄膜之光的散射度的折射率,是以,隨著穿透薄膜之目標 物的顏色、尺寸或位置的扭曲率降低,雙折射及延滞 (Retardation)情況亦減低。因此,本發明的聚亞醯胺膜可被 應用於要求透明度的領域中。 200900431 為達此目的’本發明所使用的芳香族二酸酐並無特別 限制,但包括一種化合物,或是二種或多種化合物的混合 物’該化合物係選自2,2-雙(3,4-二羧基笨基)六氟丙烷: 酸酐(6-FDA)、及4_ (2,5_二氧四氫呋喃_3_基) 5四氫化萘-1,2-二羧酸酐(TDA)以及4,4,- (4,4,-異丙烯基二 苯氧基)雙(鄰笨二甲酸酐)(HBDA)。 並且’本發明所使用的芳香族二胺並無特別限制,但 包括一種化合物’或是二種或多種化合物的混合物,該化 合物係選自氧化二苯胺(〇DA)、1,3-雙(3-胺基苯氧基)苯 10 (APB-133)、1,3-雙(4-胺基苯氧基)苯(APB-134)、1,4-雙 (4-胺基苯氧基)苯(ΑρΒ·144)、雙(3_胺基苯基)砜 (3-DDS)、雙(4-胺基苯氧基)砜(4-DDS)、2,2,-雙(三氟 曱基)-4,4’-二胺基聯苯(2,2,-丁尸03)、3,3,-雙(三氟甲基) -4,4’-二胺基聯苯(3,3’-TFDB)、2,2’-雙[4 (4_胺基苯氧基) 15苯基]六氟丙烷(4-BDAF)、2,2’-雙[3 (3-胺基苯氧基)苯基] 六氟丙烷(3-BDAF)、4,4’-雙(3-胺基苯氧基)二笨基砜 (DBSDA)以及2,2-雙[4- (4-胺基苯氧基)苯基]丙烷 (6-HMDA)。 二酸酐及二胺係以等莫耳量溶解於有機溶劑中,之後 2〇 進行反應,以製備聚醯胺酸溶液。 反應條件並無特別限制,但包括負20至80°C的反應 溫度,以及2至48小時的反應時間。此外,反應宜在氬氣 或氮氣的惰性氣體環境中進行。 用於單體之溶液聚合反應的有機溶劑,並無特別限 12 200900431 制,只要聚醯胺酸能夠溶解於其内即可。一般已知的反應 溶劑中,係使用一種或多種選自下列的極性溶劑··間—甲 酚、N-甲基-2-π比嘻烷嗣(NMP)、二甲基甲醯胺(DMF)、二 甲基乙醯胺(DMAc)、二甲基亞砜(DMS0)、丙酮以及二乙 5基醋酸鹽。此外,亦可使用低沸點溶劑,諸如四氫呋喃(THF) 或乳仿,或疋低吸收性溶劑,諸如丁内酉旨。 有機溶劑的用量並無特別限制,而為了得到具有適當 刀子里與黏度的聚醯胺酸溶液,以聚醯胺酸溶液的總量為 基準,有機溶劑的使用量較佳為5〇至%重量百分比 10 (wt%),且更佳為70至90重量百分比。 成外,當聚亞醯胺膜係使用聚醯胺酸溶液來製造時, 可添加填料至聚醯紐溶液中’以增進聚亞醯胺膜的種種 性質’包括滑動性、導熱性、導電性及耐電暈性。填料並 15200900431 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a colorless and transparent polyimide film. [Prior Art] 5 In general, polyiminamide (PI) resin is related to high heat resistant resin obtained by ring closure and dehydration reaction of polylysine at high temperature, and polyamine acid is transmitted through aromatic The acid anhydride is obtained by a solution polymerization of an aromatic diamine or an aromatic diisocyanate. In the preparation of the poly-stylenin resin, the aromatic dianhydride includes, for example, pyromellitic dianhydride (PMDA) or pyromellitic dianhydride 10 (BPDA); and the aromatic diamine includes, for example, diphenylamine oxide. (〇DA), p-phenylenediamine (p-PDA), m-phenylenediamine (m_PDA), methylene diphenylamine (MDA), and diaminophenyl hexafluoropropane (hfda). Polyimide resin, which is insoluble, refractory, and extremely heat-resistant, has excellent properties including heat resistance, oxidation resistance, radiation resistance, low temperature resistance, and chemical resistance, and is used in various fields. It includes advanced heat-resistant materials such as automotive materials, aerospace materials or aerospace materials, and electronic materials such as insulating coating agents, insulating films, semiconductors, or electrode protective films for TFT-LCDs. Recently, polyamidamide resins have been used as display materials, such as mixing conductive fillers with polymers, or coating conductive coatings on the surface of polymer films, forming optical fibers or liquid crystal alignment layers, and being transparent. Electrode film. However, the high aromatic ring density of the polyamidene resin interacts with charge transfer to cause it to become brown or yellow, so that the light transmittance in the visible light range is annoyingly reduced. The yellow or brown color of the polyamide resin makes it difficult to apply in the field of transparency required to require 6 200900431. This (4) title 'many purified monomers and high-purity solvents for A ', has been achieved' but has little effect on the improvement of light transmittance. A method in which a (4) hetero-dianhydride is formed into a knife to replace a scented dianhydride is classified. Although this method is compatible with the purification method. The transparency and color of the liquid phase or the film phase, however, are still limited in terms of improving light transmission, and the goal is to achieve high transparency, and the thermal and mechanical properties thereof are also deteriorated. 10 15 20 in U.S. Patent Nos. 4,595,548, 4,601,061, 4,458,824, 5,972, 5,158,083, 5,093,453, 5,218,077, 5,367,046, 5,338,826, 5,986, 36, and 10, and Korean Patent Publication No. 2 Cutting 0〇9437, bribe_preparation of a novel structure of polyimidate' improves light transmittance and color transparency in a range where thermal properties are not significantly reduced, mainly using such as _〇_, _8〇2_ or a linking group of CH2_, a bent structure formed by a hetero (P_pGSiti〇n) linkage at a meta position (m_pGsitiGn), or an aromatic diacid field and an aromatic second having a substituent of _cf3 Amine monomer. However, such polytertamide has been confirmed to be insufficient for use in a semiconductor film "TFT_IXD insulating film, an electrode film, and a flexible display substrate" in terms of mechanical properties and visible light transmittance. SUMMARY OF THE INVENTION Accordingly, the present invention provides a polyimide film which is colorless and transparent and exhibits excellent properties including mechanical properties and thermal stability. According to a preferred embodiment of the present invention, there is provided a polyamidamine film made of a polymer of an aromatic diacid 7 200900431 liver and an aromatic diamine, which is based on a film thickness of 50 to 100 μm. The ultraviolet spectrophotometer measures the light transmittance 'having an average light transmittance equal to or greater than 85% at a wavelength of 380 to 780 nm and having a yellow index equal to or less than 15. 5 The polyimide film according to this embodiment has a light transmittance measured by an ultraviolet spectrophotometer based on a film thickness of 50 to 1 μm, and may have a wavelength equal to or greater than a wavelength of 551 to 780 nm. The average light transmittance of 88% may have a light transmittance equal to or greater than 88% at a wavelength of 550 nm and may be equal to or greater than 85 °/ at a wavelength of 5〇〇11111. The light transmittance, and at a wavelength of 42 〇 ίο nm, may have a light transmittance equal to or greater than 50%. The polyacrylamide film according to this embodiment can have an optical density of less than 50 at a wavelength of 420 nm based on a film thickness of 5 Å to 1 Å μη. In the polyamidamine film according to this embodiment, the aromatic dianhydride may comprise a compound or a mixture of two or more compounds selected from the group consisting of 2,2-bis (3,4-di) Carboxyphenyl) hexafluoropropane dianhydride (6, FDA), 4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3, 4-tetrahydronaphthalene-1,2-if (4-(2,5-dioxotetrahydrofuran-3-yl)-l,2,3,4-tetrahydronaphthalene-l,2-dicarboxylic anhydride, TDA) and 2〇4, 4'-(4,4'-Isopropenyldiphenoxy) bis(phthalic anhydride), HBDA). In the polyamidamine film according to this embodiment, the aromatic diamine may comprise a compound or a mixture of two or more compounds selected from the group consisting of oxydianiline (ODA), 1, 3-bis(3-aminophenoxy)benzene (APB-133), 1,3-bis(4-aminophenoxy)benzene (1,3) -bis(4-aminophenoxy)benzene, APB-134), 1,4-bis(4-aminophenoxy)benzene 5 (1,4-bis(4_aminophenoxy)benzene, APB-144), double (3- Bis(3-aminophenyl)sulfone, 3-DDS, bis(4-aminophenyl)sulfone, 4-DDS, 2,2'- Bis(trifluoromethyl)-4,4'-diaminobiphenyl (2,2'-1^(1;11£111〇1:〇11^]1>4)-4,4'-diaminobiphenyl , 2,2'-butyl fluorene 08), 3,3'-bis(trifluoromethyl)-4,4,-10 diaminobiphenyl (3,3'-bis(trifluoromethyl)-4,4' -diaminobiphenyl, 3,3'-TFDB), 2,2'-bis[4 (4-aminophenoxy)phenyl]hexafluoropropane (2,2,-bis[4(4-aminophenoxy)phenyl] Hexafluoropropane, 4-BD AF), 2,2'-bis [3 (3-amino) Oxy)phenyl]hexafluoropropane (2,2,-bis[3(3-aminophenoxy)phenyl]hexafluoropropane, 3-BD 15 AF), 4,4'-bis(3-aminophenylindenyl) Phenylsulfone (4,4J-bis(3-aminophenoxy)diphenylsulfone, DBSDA) and 2,2-bis[4-(4-aminophenoxy)phenyl]propane (2,2-bis[4-( 4-aminophenoxy)phenyl]propane, 6-HMDA). The polyamidamine film according to the third embodiment may have a dielectric constant of 3.0 or less at a frequency of 50 to 100 μm based on the film thickness of 50 to 100 μm. The polyamidamine film according to the third embodiment may have an average coefficient of thermal expansion (CTE) of 50 ppm or less at 50 to 200 ° C based on a film thickness of 50 to 100 μm. 9 200900431 The polyimide film according to the third embodiment may have a modulus equal to or greater than 30 GPa based on the film thickness of 5 Å to 1 Å μηη. The polyamidamine film according to the second embodiment may have a 50% ultraviolet cut-off wavelength of 40011111 or less based on a film thickness of 50 to 100. The present invention can provide a polyacrylamide resin which is colorless and transparent and has excellent properties including mechanical properties and thermal stability, and thus can be used in various fields including a semiconductor insulating film, a TFT_LCD insulating film, a passivation film, and a liquid crystal alignment. Layer, optical communication material, protective film for solar cells, and soft 10-display substrate. The present invention also provides a liquid crystal alignment layer and a poly-aniline film using the polyamidamine resin. BRIEF DESCRIPTION OF THE DRAWINGS The first figure is a 15 piece of a polyimide film placed on a sheet of paper of Example 1, and the second picture is a film of a polyimide film of Comparative Example 1 placed on a piece of paper. photo. [Embodiment] The present invention will be described in detail later. The polyamidamine film of the present invention is a film of a polyamidamide resin prepared from a copolymer of a diamine and a dianhydride, particularly a colorless transparent polyimide film. The polyamidamine film prepared by the invention has a light transmittance of 50 to 1 〇〇μη based on a film thickness of 200900431, and is measured by an ultraviolet spectrophotometer at a wavelength of 38 〇 to 780 nm. An average light transmittance greater than 85%, and having a yellow index equal to or less than 15. , 'In addition, the polyimide film is based on a film thickness of 50 to 100 μm, and 5 is measured by an ultraviolet spectrophotometer. When the wavelength is 551 ^ 78 〇 nm, it is preferably equal to or The average light transmittance of more than 88% preferably has a light transmittance equal to or greater than 88% at a wavelength of 550 nm, and preferably has a light transmittance equal to or greater than 85% at a wavelength of 500 nm. And at a wavelength of 42 〇 nm, it is preferred to have a light transmittance equal to or greater than 5%. 10 The polyiminamide film of the present invention which meets the aforementioned light transmittance and yellow index can be applied to a field in which a conventional yellow polyimide film is difficult to apply and has high transparency requirements, including protection of TFT_LCD or diffusion. The board and the layer, such as the interlayer of the TFT-LCD, the gate insulating layer ((10) Insulator) and the liquid crystal alignment layer. When transparent polyimide is applied to the liquid crystal alignment layer, it contributes to the improvement of porosity, so that a TFT-LCD with high contrast can be manufactured, and transparent polyimide can also be used for a flexible display substrate (Flexible Display Substrate) ). The polyiminamide film of the present invention may have an optical density of less than 5 Å at a wavelength of 420 nm based on the thickness of 50 to 100. A polyamidamine film conforming to the aforementioned optical density and light transmittance of 2 , reduces the refractive index of the light used to indicate the light penetrating the film, so that the color and size of the target penetrating the film Or the positional distortion rate is reduced, and the birefringence and retardation are also reduced. Therefore, the polyamidamine film of the present invention can be applied to a field requiring transparency. 200900431 For the purpose of the invention, the aromatic dianhydride used in the present invention is not particularly limited, but includes a compound or a mixture of two or more compounds selected from the group consisting of 2,2-bis (3,4- Dicarboxyl phenyl) hexafluoropropane: anhydride (6-FDA), and 4_(2,5-dioxotetrahydrofuran-3-yl) 5 tetrahydronaphthalene-1,2-dicarboxylic anhydride (TDA) and 4,4 ,-(4,4,-isopropenyldiphenoxy) bis(o-dimethanedicarboxylic anhydride) (HBDA). And the aromatic diamine used in the present invention is not particularly limited, but includes a compound 'or a mixture of two or more compounds selected from the group consisting of oxidized diphenylamine (〇DA) and 1,3-double ( 3-aminophenoxy)benzene 10 (APB-133), 1,3-bis(4-aminophenoxy)benzene (APB-134), 1,4-bis(4-aminophenoxy) Benzene (ΑρΒ·144), bis(3-aminophenyl)sulfone (3-DDS), bis(4-aminophenoxy)sulfone (4-DDS), 2,2,-bis(trifluoro Indenyl)-4,4'-diaminobiphenyl (2,2,-butyrin 03), 3,3,-bis(trifluoromethyl)-4,4'-diaminobiphenyl (3 , 3'-TFDB), 2,2'-bis[4(4-aminophenoxy)15phenyl]hexafluoropropane (4-BDAF), 2,2'-bis[3 (3-amino group) Phenoxy)phenyl]hexafluoropropane (3-BDAF), 4,4'-bis(3-aminophenoxy)disuccinylsulfone (DBSDA) and 2,2-bis[4- (4- Aminophenoxy)phenyl]propane (6-HMDA). The dianhydride and the diamine are dissolved in an organic solvent in an equivalent molar amount, and then reacted to prepare a polyaminic acid solution. The reaction conditions are not particularly limited, but include a reaction temperature of minus 20 to 80 ° C and a reaction time of 2 to 48 hours. Further, the reaction is preferably carried out in an inert gas atmosphere of argon or nitrogen. The organic solvent used for the solution polymerization of the monomer is not particularly limited as long as it can be dissolved in the polyacetin. In the generally known reaction solvent, one or more polar solvents selected from the group consisting of m-cresol, N-methyl-2-π-decane oxime (NMP), and dimethylformamide (DMF) are used. ), dimethylacetamide (DMAc), dimethyl sulfoxide (DMS0), acetone, and diethyl 5-acetate. Further, a low boiling point solvent such as tetrahydrofuran (THF) or milky form, or a low absorption solvent such as butyl hydrazine may also be used. The amount of the organic solvent to be used is not particularly limited, and in order to obtain a polyamic acid solution having a suitable knives and viscosity, the organic solvent is preferably used in an amount of 5 Torr to % by weight based on the total amount of the polyamidonic acid solution. The percentage is 10 (wt%), and more preferably 70 to 90% by weight. In addition, when the polyamidamine film is produced by using a polyaminic acid solution, a filler can be added to the polyfluorene solution to enhance various properties of the polyimide film, including slidability, thermal conductivity, and electrical conductivity. And corona resistance. Filler and 15

20 無特別關,但其具體範例包括二氧切、氧化欽、層狀 二氧化梦、奈米碳管、氧傾、氮切、氮化蝴、鱗酸氫 鈣、磷酸鈣及雲母。 填料的粒徑可視欲修飾之薄膜的性質及添加之填料的 類型而異,並無特麻制。填㈣平均粒錄佳在〇刪 ^0叫的範圍内,更佳在〇.〇〇5至25_的範圍内.,最 在0.01至10_的範圍内。於此情況下 輕易及有效地被修飾,且亦可展現出良好的表面:= 電性與機械性質》 S ^ 異, 13 200900431 至20重量份,較佳為0.01至10重 填料的添加量為0.001 量份。 1人/5、:的^加方法並無特別限制,但舉例來說,包括於 5 酿 二添加到聚醯胺酸溶液、完成聚 曰伯人二 應4 ’使用三輥研磨機祕填料、或 3有额的分散驗與魏賊溶液混合。20 There is no special, but specific examples include dioxo, oxidized, layered dioxide dreams, carbon nanotubes, oxygen tilting, nitrogen cutting, nitriding, calcium sulphate, calcium phosphate and mica. The particle size of the filler may vary depending on the nature of the film to be modified and the type of filler to be added, and there is no special hemp. Filling in (4) the average grain count is better than the range of 0. 〇〇 5 to 25 _, and most preferably in the range of 0.01 to 10 _. In this case, it is easily and effectively modified, and can also exhibit a good surface: = electrical and mechanical properties" S ^ different, 13 200900431 to 20 parts by weight, preferably 0.01 to 10 weight of filler is added 0.001 parts by weight. The method of adding 1 person/5,: is not particularly limited, but for example, it is included in the addition of 5 broth to the poly-proline solution, and the completion of the poly scorpion 2' using a three-roll mill secret filler, Or 3 with a dispersion test mixed with the Wei thief solution.

15 用以此方式所獲得之聚醯胺酸溶液,來製造聚亞酿 的方法並無特別限制,任何習用的已知方法均可採 =。聚醯胺酸溶㈣亞醯胺化包括,例如熱亞醯胺化及化 予”胺化’其中以化學亞醯胺化特別有效。化學亞醯胺 化疋藉由將脫水劑,包括酸酐’例如醋酸酐,以及亞醯胺 化催化劑,包括三級胺,例如異嗤琳、卜甲基*定、或吨 啶,=加到聚醯胺酸溶液中來進行。化學亞醯胺化可伴隨15 The method for producing the poly-branched acid obtained by using the polyamic acid solution obtained in this manner is not particularly limited, and any conventionally known method can be used. Polyammonium-soluble (iv) imidization includes, for example, thermal amidation and "an amination" in which chemical amidation is particularly effective. Chemical amidoximation by dehydrating agents, including anhydrides For example, acetic anhydride, and amidoxime catalyst, including tertiary amines, such as isoindolin, methylidene, or tonidine, = added to a polyamidonic acid solution. Chemical imidization can be accompanied

熱亞醯胺化-起進行,且加祕件可視魏胺酸溶液的類 型及薄膜的厚度而異。 藉由在80至200〇C下,較佳為在1〇〇至18〇〇c下,加 熱基板上的聚醯胺酸溶液,以活化脫水劑與亞醯胺化催化 劑、完成部分硬化與乾燥以得到凝膠態的聚醯胺酸膜、將 聚醯胺酸膜與基板分離、以及於200至400°C下加熱凝膠 20態的薄膜5至400秒等步驟,以獲得聚亞醯胺膜。 以此所獲得之聚亞醯胺膜的厚度並無特別限制,但考 慮到其應用領域’則膜厚較佳為在10至250 μιη的範圍内, 更佳為在25至150 μιη的範圍内。 本發明的聚亞醯胺膜於1 GHz時,具有等於或小於3 〇 14 200900431 的&quot;電⑦數,因而可用來作為半導體純化(passivati〇n)膜。 本發明的聚亞醢胺膜於50至200°C時,具有等於或小 於50 ppm的平均熱膨脹係數。若平均熱膨脹係數超過5〇 ppm時,當聚亞醯胺膜應用於將薄膜電晶體(TFT)置放到薄 5膜上的薄膜電晶體陣列(TFT ARRAY)製程時,聚亞醯胺臈 可能會隨著不同的製程溫度而收縮或膨脹,導致在電極摻 雜製程中無法達成配向。此外,薄膜亦無法保持平整,因 而可旎捲繞。所以,當熱膨脹係數減低時,TFT製程才可 能更準確地進行。 1〇 本發明的聚亞醯胺膜具有等於或大於3.0 GPa的模 數三在此範例巾’聚亞醯賴可更輕易地被顧於軟性顯 示器基板的捲壓(Roll to Roll)製程。當聚亞醯胺膜被用來作 為权性顯示器(Flexible Display)與軟性銅箔基板(FCCL)的 基膜時,係進行捲壓製程。此時,因為薄膜被滾筒捲繞以 I5及自滾筒釋放時,薄膜會受到拉力,所以模數低於3 〇GPa 的薄膜可能會斷裂。 依據使用紫外光分光光度計的透光率測量,本發明之 聚亞醯胺膜具有等於或小於铜nm之5〇%截止波長。因 此’本發明的聚亞醯胺臈可用來作為太陽能電池用的 2〇保護膜。 錄舉下列各範例以更加瞭解本發明,但所舉各範例不 得解釋為限制本發明。 &lt;範例1&gt; 當氮氣通過配備有檀拌器、氮氣入口、滴液漏斗、控 15 200900431 溫器以及冷凝器之100 mL的三頸(3-Neck)圓底燒瓶反應裝 置時,將32.4623克的N,N-二甲基乙醯胺(DMAc)加入該圓 底燒瓶内,並將反應.裝置的溫度降低到〇cC,再將4.1051 克(0.01莫耳)的6-HMDA溶解於其内。將此溶液保持在 5 〇°C 的溫度。將 3.1〇97 克(0.007 莫耳)的 6-FDA 和 0.90078 克(0.003莫耳)的TDA加入溶液中,並攪拌此混合物1 小時,直到6-FDA與TDA完全溶解。此溶液的固體含量為 2〇重量百分比(wt%)。在室溫條件下將獲得的溶液攪拌8 小4 ’以產生於23°C時’黏度為2200 cps的聚酿胺酸溶液。 10 其後,使用刮刀(Doctor Blade)在玻璃基板上塗敷厚度 500至1000 μιη的聚醯胺酸溶液,再於真空烘箱中以4〇〇c 的溫度乾燥1小時,和以60°C的溫度乾燥2小時,以產生 一種自立薄膜(Self Standing Film)。接著,讓此薄膜在高溫 烘箱中以每分鐘5°C的加熱速率,分別在8〇〇c下硬化3小 I5時、100°C下硬化1小時、2〇〇。(:下硬化丨小時以及3〇〇〇c 下硬化3〇分鐘,以產生厚度為5〇μιη^ 1〇〇μιη的聚亞酿 胺膜。 〈範例2&gt; 如同範例卜4.1051克(0 〇1莫耳)的6_HMDA係溶 2〇解於3L遍克的DMAc中,並將此溶液保持在〇〇c的溫 度。將2.2215克(0.005莫耳)的6_舰和】5〇13克(〇施 莫耳)的TDA依序加人溶財,並養此溶液丨小時,直 到6-FDA與TDA完全溶解。溶液的固體含量為2〇重量百 分比⑽%)。錢,在室溫條件下賴㈣雜獅8小時, 16 200900431 以產生於23°C時,黏度為2000 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 〈範例3&gt; 如同範例1,4.1051克(0.01莫耳)的6_HMDA係溶 5解於30.15868克的DMAc中,並將此溶液保持在〇(&gt;c的溫 度。將 1.11275 克(0.003 莫耳)的 6_FDA* 2 1〇182 克(〇 〇〇7 莫耳)的TDA依序加入溶液中,並將溶液攪拌丨小時,直 到6-FDA與TDA完全溶解。溶液的固體含量為2〇重量百 分比(wt%)。然後,在室溫條件下將溶液攪拌8小時,以產 1〇生於23°C時,黏度為18〇〇 CpS的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例4&gt; 如同範例1 ’ 2.87357克(0.007莫耳)的6_HMDA係 溶解於30.5158克的DMAc中,再將〇.7449克(0.003莫耳) u的3-DDS加入,並使其完全溶解。將31〇97克(〇 〇〇7莫 耳)的6-FDA和0.90078克(0.003莫耳)的TDA依序加 入溶液中,將溶液攪拌1小時’直到6_FDA與TDA完全溶 解。溶液的固體含量為20重量百分比(wt〇/〇)。然後,在室 溫條件下將獲得的溶液攪拌8小時,以產生一種於23〇c 20時’黏度為2000 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例5&gt; 如同範例1,2.87357克(0.007莫耳)的6-HMDA係 溶解於30·5158克的DMAc中,再將0.7449克(〇.〇〇3莫耳) 17 200900431 加人溶液中,並使其完全溶解。將3·ΐ()97克(〇.007 莫耳)的6-FDA和〇.9_克(_莫耳)的tda 加入溶液中,並將溶液攪拌!小時,直到6_fda與TDA 完全溶解。溶液的固體含量為2〇重量百分比(wt%)。然後, 5在室溫條件下將獲㈣轉攪拌8小時,域生於的 時,黏度為2000 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞_膜。 &lt;範例6&gt; 如同範例卜2.24161克(〇撕莫耳)的2,2,_丁腿和 10 0.7449克(0.003莫耳)的3七Ds係溶解於㈣克的 DMAc 中。將 3.1097 克(〇.〇〇7 莫耳)的 6_fda 和 〇 9〇〇78 克(0.003莫耳)的TDA依序加入溶液中,並將溶液授掉} 小時’直到6-FDA與TDA完全溶解。溶液的固體含量為 2〇重量百分比(wt%)。然後,在室溫條件下將溶液擾摔8 15小日τ,以產生於23〇C時’黏度為2〇〇〇 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例7&gt; 如同範例卜2.24161克(〇 〇〇7莫耳)的2,2,_tfdb和 0.7449克(0.003莫耳)的4七Ds,係溶解於27 98796克 20 的 DMAc 中。將 3.1097 克(〇.〇〇7 莫耳)的 6 fda 和 〇 9〇〇78 克(0.003莫耳)的TDA依序加入溶液中,並將溶液授摔i 小時,直到6-FDA與TDA完全溶解。溶液的固體含量為 20重量百分比(wt%)。然後,在室溫條件下將溶液攪拌8 小日守以產生於23 C時’黏度為2〇〇〇 cps的聚醯胺酸溶液。 200900431 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例8&gt; 如同範例卜3.62922克(0.007莫耳)的4-BDAF係溶 解於33.5386克的DMAc中,再將0.7449克(0.003莫耳) 5的3_DDS加入溶液中,並使其完全溶解。將3 克(〇 莫耳)的6-FDA和0.90078克(0.003莫耳)的TDA依序 加入溶液中,並將溶液擾拌1小時,直到6_fda與TDA 完全溶解。溶液的固體含量為20重量百分比(wt%)。然後, 在室溫條件下將溶液攪拌8小時,以產生於23〇c時,黏度 10 為2200 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例9&gt; 如同範例1,3.62922克(0.007莫耳)的4_BDAF係溶 解於33.5386克的DMAc中,再將0.7449克(0.003莫耳) 15的4-DDS加入溶液中,並使其完全溶解。將3.1097克(0.007 莫耳)的6-FOA和0.90078克(0.003莫耳)的TDA依序 加入溶液中’並將溶液撥摔1小時,直到6-FDA斑XDA 完全溶解。溶液的固體含量為20重量百分比(wt%;)。然後, 在室溫條件下將溶液攪拌8小時,以產生於23〇c時,黏度 20為2100 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例10&gt; 如同範例卜2.04631克(0.007莫耳)的APB_133和 0.7449克(0.003莫耳)的3-DDS,係完全溶解於27.20696 200900431 克的DMAC中。將3.膽75克(0·007莫耳)的6_FDA和 0.90078克(0.003莫耳)的TDA依序加入溶液中,並將獲 得的溶液赫1小時,直到6_FDA與TDA完全溶解。溶液 的固體含量為20重量百分比(wt%)。然後,在室溫條件下 5將溶液授拌8小時,以產生於23〇(:時,黏度為謂cps的 聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例11&gt; 如同範例卜2.04631克(0.007莫耳)的ΑΡΒ·133和 ίο 0.7449克(0.003莫耳)的4_DDS,係完全溶解於27 2〇696 克的DMAe中。將3.10975克(0.007莫耳)的6_FDA和 0.90078克(0.003莫耳)的TDA依序加入溶液中,並將混 合物攪拌1小時,直到6-FDA與TDA完全溶解。所獲得之 /谷液的固體含直為20重量百分比(wt%)。然後,在室溫條 I5件下將溶液攪拌8小時,以產生於23。(:時,黏度為I950 cps 的聚醢胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺臈。 &lt;範例12&gt; 如同範例1,3.2023克(〇.〇1莫耳)的2,2,-TFDB係完 2〇全溶解於30_986克的DMAc中。將此溶液保持在〇〇c的溫 度。將 3.64355 克(0.007 莫耳)的 6-HBDA 和 0.90078 克 (0.003莫耳)的TDA依序加入溶液中,並將混合物擾拌1 小時,直到6-HBDA與TDA完全溶解。所獲得之溶液的固 體含量為20重量百分比(wt%)。然後,在室溫條件下將溶 200900431 液攪拌8小時,以產生於23〇c時,黏度為2〇〇〇cps的聚醯 胺酸溶液。 其後,採用如同範例〗的方式製造聚亞醯胺膜。 &lt;範例13&gt; 5 如同範例1 ’ 2.483克莫耳)的4-DDS係溶解於 28.1093克的DMAc中’將溶液保持在〇〇c的溫度。將 3.64355 克(0.007 莫耳)的 6_HBDA 和 〇 9〇〇78 克(〇 〇〇3 莫耳)的TDA依序加入溶液中,並將溶液攪拌丨小時,直 到6-HBDA與TDA完全溶解。溶液的固體含量為2〇重量 10百分比(wt%)。然後,在室溫條件下將溶液攪拌8小時,以 產生於23°C時,黏度為18〇〇 CpS的聚酿胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例14&gt; 如同範例1,5.1846克(〇.〇1莫耳)的4_BDAF係溶解 U於38.9157克的DMAc中,並將溶液保持在的溫度。 將 3.64355 克(0_007 莫耳)的 6-HBDA 和 0.90078 克(0.003 莫耳)的TDA依序加入溶液中,並將溶液攪拌1小時,直 到6-HBDA與TDA完全溶解。溶液的固體含量為2〇重量 百分比(wt%)。然後’在室溫條件下將溶液攪拌8小時,以 20產生於23°c時,黏度為200〇 cps的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜。 &lt;範例15&gt; 如同範例1 ’ 2.24161克(0.007莫耳)的2,2,-TFDB和 0.7449克(0.003莫耳)的4-DDS,係完全溶解於30.3628 21 200900431 克的DMAc中。將溶液保持在〇〇c的溫度。將3細克 (0.007 莫耳)的 6_HBDA 和 〇.96〇69 克(〇 〇〇3 莫耳)的 TDA依序加入溶液中,並攪拌i小時,直到6_hbda盘 完全溶解。溶液的㈣含量為2G重量百分比(wt%)。狹後, 在室溫條件下將溶賴拌8小時,以產生於沉時,黏度 為1700 cps的聚醯胺酸溶液。The thermal amidation is carried out, and the addition of the secret component may vary depending on the type of the proline solution and the thickness of the film. Heating the polylysine solution on the substrate at 80 to 200 ° C, preferably at 1 to 18 ° C, to activate the dehydrating agent and the hydrazide catalyst to complete partial hardening and drying To obtain a poly-proline film in a gel state, to separate a poly-proline film from a substrate, and to heat a film in a gel state at 200 to 400 ° C for 5 to 400 seconds to obtain a polyamidamine. membrane. The thickness of the polyimide film thus obtained is not particularly limited, but the film thickness is preferably in the range of 10 to 250 μηη, more preferably in the range of 25 to 150 μηη, in view of the field of application thereof. . The polyimine film of the present invention has an electric number of 1 GHz 14 200900431 at 1 GHz, and thus can be used as a semiconductor purification film. The polyiminamide film of the present invention has an average coefficient of thermal expansion equal to or less than 50 ppm at 50 to 200 °C. If the average coefficient of thermal expansion exceeds 5 〇 ppm, when the polyimide film is applied to a thin film transistor array (TFT ARRAY) process in which a thin film transistor (TFT) is placed on a thin 5 film, polyamidoguanidine may be used. It will shrink or expand with different process temperatures, resulting in failure to achieve alignment in the electrode doping process. In addition, the film cannot be kept flat and can be wound up. Therefore, when the coefficient of thermal expansion is reduced, the TFT process can be performed more accurately. The polyimide film of the present invention has a modulus of three or more and 3.0 GPa. In this example, the polyimide film can be more easily taken into account in the roll-to-roll process of the flexible display substrate. When a polyimide film is used as a base film of a flexible display and a soft copper foil substrate (FCCL), a roll press is performed. At this time, since the film is subjected to tension when it is wound by the drum with I5 and released from the drum, the film having a modulus of less than 3 〇GPa may be broken. The polyimide film of the present invention has a cutoff wavelength of 5 % or less of copper nm, which is measured according to the transmittance using an ultraviolet spectrophotometer. Therefore, the polyamidamine of the present invention can be used as a 2-inch protective film for solar cells. The following examples are included to better understand the present invention, but the examples are not to be construed as limiting the invention. &lt;Example 1&gt; When nitrogen gas was passed through a 100 mL three-neck (3-Neck) round bottom flask equipped with a sandalwood mixer, a nitrogen inlet, a dropping funnel, a condenser, and a condenser, 32.4623 g N,N-dimethylacetamide (DMAc) was added to the round bottom flask, and the temperature of the reaction apparatus was lowered to 〇cC, and 4.1051 g (0.01 mol) of 6-HMDA was dissolved therein. . This solution was maintained at a temperature of 5 〇 °C. 3.1 〇 97 g (0.007 mol) of 6-FDA and 0.90078 g (0.003 mol) of TDA were added to the solution and the mixture was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The solid content of this solution was 2% by weight (wt%). The obtained solution was stirred at room temperature for 8 hours 4' to give a poly-branched acid solution having a viscosity of 2200 cps at 23 °C. 10 Thereafter, a polyamic acid solution having a thickness of 500 to 1000 μm was applied on the glass substrate using a doctor blade, and then dried in a vacuum oven at a temperature of 4 ° C for 1 hour, and at a temperature of 60 ° C. It was dried for 2 hours to produce a Self Standing Film. Next, the film was allowed to harden at a heating rate of 5 ° C per minute in a high-temperature oven at 3 ° C for 8 hours, and at 100 ° C for 1 hour, 2 Torr. (: under hardening for 丨 hours and 3 〇〇〇c for 3 〇 minutes to produce a polyacrylamide film having a thickness of 5 〇μιη^ 1 〇〇 μηη. <Example 2> As an example, 4.1051 g (0 〇1) 6_HMDA is dissolved in 3L gram of DMAc, and this solution is maintained at the temperature of 〇〇c. 2.2215 g (0.005 m) of 6_ ship and 5 〇 13 g (〇 The TDA of Schmöll was added to the solution in a timely manner, and the solution was raised for a few hours until the 6-FDA and TDA were completely dissolved. The solid content of the solution was 2% by weight (10% by weight). Money, at room temperature, Lai (four) lions for 8 hours, 16 200900431 to produce a polylysine solution with a viscosity of 2000 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. <Example 3> As in Example 1, 4.1051 g (0.01 mol) of 6_HMDA was dissolved in 30.15868 g of DMAc, and this solution was maintained at a temperature of 〇(&gt;c. 1.11275 g (0.003 m) 6_FDA* 2 1〇182 g (〇〇〇7 mol) of TDA was added to the solution in sequence, and the solution was stirred for a few hours until the 6-FDA and TDA were completely dissolved. The solid content of the solution was 2% by weight ( Then, the solution was stirred at room temperature for 8 hours to produce a polyphthalic acid solution having a viscosity of 18 〇〇CpS at 23 ° C. Thereafter, the same manner as in Example 1 was employed. A polyimide film was produced. &lt;Example 4&gt; As in Example 1 ' 2.87357 g (0.007 mol) of 6_HMDA was dissolved in 30.5158 g of DMAc, and then 7 449 g (0.003 mol) of 3-DDS Add and completely dissolve. Add 31〇97g (〇〇〇7mol) of 6-FDA and 0.90078g (0.003m) of TDA to the solution in sequence and stir the solution for 1 hour' until 6_FDA with The TDA is completely dissolved. The solid content of the solution is 20% by weight (wt〇/〇). Then, it will be obtained at room temperature. The solution was stirred for 8 hours to produce a polylysine solution having a viscosity of 2000 cps at 23 ° C. Thereafter, a polyimine film was produced in the same manner as in Example 1. &lt;Example 5&gt; 1, 2.87357 g (0.007 mol) of 6-HMDA was dissolved in 30·5158 g of DMAc, and 0.7449 g (〇.〇〇3 mol) 17 200900431 was added to the solution and completely dissolved. 3 ΐ () 97 g (〇.007 mol) of 6-FDA and 〇.9_g (_mole) of tda was added to the solution, and the solution was stirred for an hour until 6_fda and TDA were completely dissolved. The solid content of the solution was 2% by weight (wt%). Then, 5 (4) was stirred at room temperature for 8 hours, and the polyamic acid solution having a viscosity of 2000 cps was born. A poly-Asian film was produced in the same manner as in Example 1. &lt;Example 6&gt; As an example, 2.241161 g (〇 莫 )) 2, 2, _ legs and 10 0.7 449 g (0.003 m) of 3 7 Ds Dissolved in (four) grams of DMAc. Add 3.1097 grams (〇.〇〇7 Moer) of 6_fda and 〇9〇〇78 grams (0.003 moles) of TDA sequentially. Solution, and the solution was granted off} h 'until 6-FDA and TDA was completely dissolved solids content of the solution is 2〇 weight percent (wt%). Then, the solution was disturbed at room temperature for 8 15 hours τ to produce a polyaminic acid solution having a viscosity of 2 〇〇〇 cps at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 7&gt; As in the example, 2.241161 g (〇7 mol) of 2,2,_tfdb and 0.7449 g (0.003 mol) of 4 7 Ds were dissolved in 27 98796 g of 20 DMAc. Add 3.1097 g (〇.〇〇7 Moel) of 6 fda and 〇9〇〇78 g (0.003 mol) of TDA to the solution in sequence, and dispense the solution for 1 hour until 6-FDA and TDA are completely Dissolved. The solid content of the solution was 20% by weight (wt%). Then, the solution was stirred at room temperature for 8 hours to produce a polyaminic acid solution having a viscosity of 2 〇〇〇 cps at 23 C. 200900431 Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 8&gt; As in the example, 3.62922 g (0.007 mol) of 4-BDAF was dissolved in 33.5386 g of DMAc, and then 0.7449 g (0.003 mol) of 5_DDS was added to the solution, and completely dissolved. 3 grams of 6-FDA and 0.90078 grams (0.003 moles) of TDA were added to the solution sequentially, and the solution was scrambled for 1 hour until 6_fda and TDA were completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyaminic acid solution having a viscosity of 10 at 2200 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 9&gt; As in Example 1, 3.62922 g (0.007 mol) of 4_BDAF was dissolved in 33.5386 g of DMAc, and then 0.7449 g (0.003 mol) of 15-DDS was added to the solution and completely dissolved. . 3.1097 g (0.007 mol) of 6-FOA and 0.90078 g (0.003 mol) of TDA were sequentially added to the solution' and the solution was dropped for 1 hour until the 6-FDA spot XDA was completely dissolved. The solid content of the solution was 20% by weight (wt%;). Then, the solution was stirred at room temperature for 8 hours to give a polyaminic acid solution having a viscosity of 20 at 2100 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 10&gt; As in the example, 2.04631 g (0.007 mol) of APB_133 and 0.7449 g (0.003 mol) of 3-DDS were completely dissolved in the DMAC of 27.20696 200900431 g. 6 FDA and 3.0078 g (0.003 mol) of TDA were added sequentially to the solution, and the obtained solution was allowed to stand for 1 hour until 6_FDA and TDA were completely dissolved. The solid content of the solution was 20% by weight (wt%). Then, the solution was mixed for 8 hours at room temperature to give a polyamic acid solution having a viscosity of 23 Å at 23 Å. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 11&gt; As in the example, 2.04631 g (0.007 mol) of ΑΡΒ·133 and ίο 0.7449 g (0.003 mol) of 4_DDS, completely dissolved in 27 2〇696 g of DMAe. 3.10975 g (0.007 6_FDA and 0.90078 g (0.003 mol) of TDA were added to the solution in sequence, and the mixture was stirred for 1 hour until the 6-FDA and TDA were completely dissolved. The obtained solids of the solution were directly 20 weights. Percentage (wt%). Then, the solution was stirred for 8 hours under room temperature I5 to give a poly(prolinic acid solution) having a viscosity of I950 cps. Thereafter, the method was as in Example 1. Production of polyamidoguanidine. &lt;Example 12&gt; As in Example 1, 3.2023 g (〇.〇1 mol) of 2,2,-TFDB was completely dissolved in 30-986 g of DMAc. The temperature at 〇〇c. 3.64355 g (0.007 m) of 6-HBDA and 0.90078 g (0.003 m) TDA was added to the solution in sequence, and the mixture was scrambled for 1 hour until 6-HBDA and TDA were completely dissolved. The obtained solution had a solid content of 20% by weight (wt%). Then, it was dissolved at room temperature 200900431 The solution was stirred for 8 hours to give a polyaminic acid solution having a viscosity of 2 〇〇〇 cps at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in the example. &lt;Example 13&gt; Example 1 '2.483 gmol' of the 4-DDS system was dissolved in 28.1093 g of DMAc' to maintain the solution at 〇〇c. 3.64355 g (0.007 mol) of 6_HBDA and 〇9〇〇78 g (〇 T3 Mox) TDA was added to the solution sequentially, and the solution was stirred for a few hours until 6-HBDA and TDA were completely dissolved. The solid content of the solution was 2 〇 by weight 10% (wt%). Then, at room temperature The solution was stirred for 8 hours to give a poly-aramidic acid solution having a viscosity of 18 〇〇 CpS at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 14&gt; As in Example 1, 5.1846 g (〇.〇1 Moel) of 4_BDAF is dissolved in U at 38.91 57 g of DMAc and keep the solution at the temperature. 3.64355 g (0_007 mol) of 6-HBDA and 0.90078 g (0.003 mol) of TDA were added to the solution sequentially, and the solution was stirred for 1 hour until 6-HBDA is completely dissolved with TDA. The solid content of the solution was 2% by weight (wt%). Then, the solution was stirred at room temperature for 8 hours to obtain a polyaminic acid solution having a viscosity of 200 〇 cps at 23 ° C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Example 15&gt; As in Example 1 ' 2.24161 g (0.007 mol) of 2,2,-TFDB and 0.7449 g (0.003 mol) of 4-DDS, it was completely dissolved in 30.3628 21 200900431 g of DMAc. The solution is maintained at the temperature of 〇〇c. 3 μg (0.007 mol) of 6_HBDA and 〇.96〇69 g (〇 3 mol) of TDA were sequentially added to the solution and stirred for 1 hour until the 6-hbda disk was completely dissolved. The (iv) content of the solution was 2 G weight percent (wt%). After the narrowing, the solution was mixed for 8 hours at room temperature to produce a polyaminic acid solution having a viscosity of 1700 cps at the time of sedimentation.

其後,採用如同範例1的方式製造聚亞 &lt;範例16&gt; 醯胺膜 如同範例卜遍22克(0·〇〇7莫耳)的· 1〇 〇古谓克(議莫耳)的4侧,係完全溶解於π謂 克的DMAc中。將溶液保持在〇〇c的溫度。们細克 (0.007 莫耳)的 6_HBDA 和 0.96069 克(〇 〇〇3 莫耳)的 TDA依序加入溶液中,並授拌i小時,直到6_hbda盘tda 完全溶解。溶賴_含量為2G重量百分比(wt%)。缺後, 在室溫條件下將溶賴拌8小時,以產生於挪時,黏度 為1700 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞酿胺膜。 &lt;範例17&gt; 如同範例卜2.24161克(_7莫耳)的2,2,_tfdb和 1.55538《(G.GG3莫耳)的3_BDAF,係加人並完全溶解於 33.60472克的DMAc中。將溶液保持在〇〇c的溫度。將 3:6435 克(0·007 莫耳)的 6_HBDA 和 〇 96〇69 克(〇細 莫耳)的TDA依序加入溶液中,並餅i小時,直到6_hbda 與TDA完全溶解。溶液的固體含量為2〇重量百分比 22 200900431 (wt%)。然後’在室溫條件下將溶液攪拌8小時,以產生於 23°C時,黏度為1800 cps的聚醯胺酸溶液。 其後’採用如同範例1的方式製造聚亞醯胺膜。 &lt;比較範例1&gt; 5 如同範例1,5.1846克(0.01莫耳)的4-BDAF係溶解 於38.5084克的DMAc中,接著將4.4425克(0.01莫耳) 的6-FOA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 件下將溶液攪拌8小時,以產生於23°C時,黏度為1300 cps ίο的聚醯胺酸溶液。 其後,採用如同範例1的方式製造聚亞醯胺膜,而所 得之膜厚分別為25 μπι,50 μιη及1〇〇 μιη。 &lt;比較範例2&gt; 如同範例1,2.9233克(0.01莫耳)的ΑΡΒ·133係溶 I5解於29.4632克的DMAc中’接著將4.4425克(0.01莫耳) 的6-FDA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 件下將溶液攪拌8小時,以產生於23。(:時,黏度為12〇〇 cps 的聚醯胺酸溶液。 20 其後,採用如同比較範例1的方式製造聚亞醯胺膜。 &lt;比較範例3&gt; 如同範例1,2.4830克(〇.〇1莫耳)的3_DDS係溶解 於27.702克的DMAc中’接著將4.4425克(〇.〇1莫耳)的 6-FDA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 23 200900431 溶液的固體含量為20重量百分比(wt〇/0)。然後,在室溫條 件下將溶液攪拌8小時,以產生於23。(:時,黏度為1300 cps 的聚醯胺酸溶液。 其後’採用如同比較範例1的方式製造聚亞醯胺膜。 5 &lt;比較範例4&gt; 如同範例1,2.4830克(〇.〇1莫耳)的4-DDS係溶解 於27.702克的DMAc中,接著將4.4425克(〇·〇1莫耳)的 6-FDA加入。將溶液攪拌1小時,直到6_FDA完全溶解。 溶液的固體含量為20重量百分比(wt%)。然後,在室溫條 10件下將溶液攪拌8小時’以產生於23°C時,黏度為1400 cps 的聚醯胺酸溶液。 其後’採用如同比較範例1的方式製造聚亞醯胺膜。 &lt;比較範例5&gt; 如同範例卜2.0024克(〇.〇1莫耳)的3,3,_〇da係溶 15解於25.7796克的DMAc中’接著將4 4425克(〇 〇1莫耳) 的6-FDA加入,並將獲得的溶液攪拌j小時,直到6_FDA 完全溶解。溶液的固體含量為2 0重量百分比(wt %)。然後, 在室溫條件下將溶液攪拌8小時,以產生於23〇c時,黏度 為1600 cps的聚醯胺酸溶液。 2〇 錢’採用如同比較範例1的方式製造聚亞醯胺膜。 &lt;比較範例6&gt;Thereafter, a poly Asia &lt;Example 16&gt; guanamine film was produced in the same manner as in Example 1 as an example of a gram of 22 g (0·〇〇7 Moel). On the side, it is completely dissolved in DMAc of π-gram. The solution is maintained at the temperature of 〇〇c. We finely (0.007 mol) of 6_HBDA and 0.96069 g (〇 〇〇3 mol) of TDA were added to the solution sequentially and mixed for 1 hour until the 6_hbda tray tda was completely dissolved. The dissolved _ content was 2 G weight percent (wt%). After the absence, the solution was mixed for 8 hours at room temperature to produce a polyaminic acid solution having a viscosity of 1700 cps. Thereafter, a poly-aniline film was produced in the same manner as in Example 1. &lt;Example 17&gt; As in the example, 2.241161 g (_7 mol) of 2,2,_tfdb and 1.55538 ((G.GG3 Moer) 3_BDAF were added and completely dissolved in 33.60472 g of DMAc. The solution is maintained at the temperature of 〇〇c. 3:6435 g (0·007 mol) of 6_HBDA and 〇96〇69 g (〇细莫) of TDA were sequentially added to the solution and caked for 1 hour until 6_hbda and TDA were completely dissolved. The solids content of the solution is 2% by weight 22 200900431 (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyamic acid solution having a viscosity of 1800 cps at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1. &lt;Comparative Example 1&gt; 5 As in Example 1, 5.1846 g (0.01 mol) of 4-BDAF was dissolved in 38.5084 g of DMAc, followed by 4.4425 g (0.01 mol) of 6-FOA. The solution was stirred for 1 hour until 6_FDA was completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give a polyamic acid solution having a viscosity of 1300 cps ίο at 23 °C. Thereafter, a polyimide film was produced in the same manner as in Example 1, and the film thicknesses were 25 μm, 50 μm and 1 μm, respectively. &lt;Comparative Example 2&gt; As in Example 1, 2.9233 g (0.01 mol) of ΑΡΒ·133 is dissolved in 29.4632 g of DMAc' followed by 4.4425 g (0.01 mol) of 6-FDA. The solution was stirred for 1 hour until 6_FDA was completely dissolved. The solid content of the solution was 20 weight percent (wt%). Then, the solution was stirred at room temperature for 8 hours to give 23. (: Polyurethane solution having a viscosity of 12 〇〇 cps. 20 Thereafter, a polyimide film was produced in the same manner as in Comparative Example 1. &lt;Comparative Example 3&gt; As Example 1, 2.4830 g (〇. The 3D DDS of 〇1 mol was dissolved in 27.702 g of DMAc. Then 4.4425 g of 6-FDA was added. The solution was stirred for 1 hour until 6_FDA was completely dissolved. 23 200900431 Solids of solution The content was 20% by weight (wt 〇 / 0). Then, the solution was stirred at room temperature for 8 hours to give a poly (proline) solution having a viscosity of 1300 cps. The polyimide film was produced in the same manner as in Example 1. 5 &lt;Comparative Example 4&gt; As in Example 1, 2.4830 g (〇.〇1 mol) of the 4-DDS system was dissolved in 27.702 g of DMAc, followed by 4.4425 g. 6-FDA addition of (〇·〇1mol). Stir the solution for 1 hour until 6_FDA is completely dissolved. The solid content of the solution is 20% by weight (wt%). Then, stir the solution at room temperature for 10 pieces. 8 hours' to produce a polyamic acid solution with a viscosity of 1400 cps at 23 ° C. 'Polyammine film was produced in the same manner as in Comparative Example 1. &lt;Comparative Example 5&gt; As an example, 2.0024 g (〇.〇1 Moel) of 3,3,_〇da is a solution of 25.7796 g. In DMAc, '4,425 g (〇〇1 mol) of 6-FDA was added, and the obtained solution was stirred for 1 hour until 6_FDA was completely dissolved. The solid content of the solution was 20% by weight (wt%). The solution was stirred at room temperature for 8 hours to produce a polyaminic acid solution having a viscosity of 1600 cps at 23 ° C. 2 〇 Money 'The polyimide film was produced in the same manner as in Comparative Example 1. &lt;;Comparative example 6&gt;

如同範例卜2.0024克(〇.〇1莫耳)的4,4,_〇DA係溶 解於16.7344克的DMAc中,接著將21812克(〇 〇1莫耳) 的PMDA加人,並將獲得的溶液授拌i小時,直到pMDA 24 200900431 完全溶解As in the example, 2.0024 g (〇.〇1 Moel) of 4,4,_〇DA is dissolved in 16.7344 g of DMAc, then 21,812 g (〇〇1 mol) of PMDA is added and will be obtained. The solution is mixed for i hours until pMDA 24 200900431 is completely dissolved

時’以產生於23°C時,黏度 在室溫條件下將溶液攪拌8小時, 為2500 p〇ise的聚醯胺酸溶液。 其後,採用如同比較範例1的方式製造聚亞醯胺膜。 上迹各範例及比較範例所製得之聚亞醯胺膜的性質, 均依下列方式所測量。結果統整於下列表丨至表4。 (1) 透光率及50%截止波長 .使用紫外光分光光度計(瓦里安科技股份有限公司, Varian,型號CarylGG),來測量各聚亞酿胺膜的可見光透光 10率及5〇%截止波長。 將臈厚為50 μιη之範例1及比較範例6的聚亞醯胺膜, 分別置於一張印有黃色文字與線條的紙上,之後拍照。結 果顯示於第一圖及第二圖。 (2) 黃色指數 15 依照ASTME313標準來測量黃色指數。 ⑶光學密度(〇D, optical density) 光學密度係依據下列方程式1予以計算: 方程式1 0£)x=s A± = --1- log 1〇Γ [ =-^- log ιο(-^·)] 其中/是膜的厚度,4是在波長為λ時的吸光度,r是 透光率’ 4是入射光強度,以及/則是透射光強度。 (4)模數 使用英特斯朗公司(Instron)的萬能試驗機(Universal 25 200900431When the solution was produced at 23 ° C, the solution was stirred at room temperature for 8 hours to obtain a 2500 p〇ise polyamine solution. Thereafter, a polyimide film was produced in the same manner as in Comparative Example 1. The properties of the polyimide membranes prepared by the above examples and comparative examples were measured in the following manner. The results are summarized in the following table to Table 4. (1) Light transmittance and 50% cut-off wavelength. The ultraviolet light spectrophotometer (Varian Technology Co., Ltd., Varian, model CarylGG) was used to measure the visible light transmittance rate of each polyacrylamide film and 5〇. % cutoff wavelength. The polyimide film of Example 1 and Comparative Example 6 having a thickness of 50 μm was placed on a sheet of paper printed with yellow characters and lines, and photographed. The results are shown in the first and second figures. (2) Yellow index 15 The yellow index is measured in accordance with the ASTM E313 standard. (3) Optical density (〇D, optical density) The optical density is calculated according to the following equation 1: Equation 1 0£)x=s A± = --1- log 1〇Γ [ =-^- log ιο(-^· Where / is the thickness of the film, 4 is the absorbance at a wavelength of λ, r is the light transmittance '4 is the incident light intensity, and / is the transmitted light intensity. (4) Modulus Using Instron's universal testing machine (Universal 25 200900431)

Testing Machine) ’ 型號 Model 1000,依照 JIS Κ 6301 狭準 來測量模數。 (5) 玻璃轉移溫度(Tg) 使用掃描式熱差分析儀(DSC,ΤΑ儀器,型號Q2〇〇 ), 5來測量玻璃轉移溫度。 (6) 熱膨脹係數(CTE) 使用熱機械分析儀(ΤΜΑ ’ ΤΑ儀器,型號Q400),依 照熱機械分析方法(TMA-Method) ’在50至200。(:下測量熱 膨脹係數。 ^ 1〇 (7)介電常數 依據ASTM D150來測量介電常數。 【表1】 組成成分 莫耳比 膜厚 (μιη) 透光率 光學密度 380 nm 至 780 nm 551 nm 至 780 nm 550 nm 500 run 420 nm 550 nm 500 nm 420 nm 範 例 1 6-FDA+TDA/6-HMDA 7:3:10 50 88.2 90.0 89.8 89.3 60.1 9.34 9.82 44.25 2 6-FDA+TDA/6-HMDA 5:5:10 50 88.0 89.9 89.7 89.3 58.9 9.44 9.83 45.98 3 6-FDA+TDA/6-HMDA 3:7:10 50 87.8 89.5 89.5 88.9 58.0 9.64 10.21 47.31 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 86.7 88.5 88.3 87.2 57.7 10.80 11.89 47.76 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 50 88.5 90.3 89.9 89.2 71.5 9.25 9.92 29.14 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 85.6 88.9 88.7 86.4 63.1 10.42 12.70 40.00 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 87.3 89.6 89.4 89.0 75.4 9.73 10.12 24.52 26 200900431 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 86.8 88.9 88.7 88.2 75.8 10.42 10.91 24.07 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 50 86.7 89.1 88.9 87.3 72.7 10.21 11.79 27.69 13 6-HBDA+TDA/4-DDS 7:3:10 50 87.1 89.5 89.1 87.6 74.6 10.02 11.50 25.5 14 6-HBDA+TDA/4-BDAF 7:3:10 50 86.6 89.2 89.0 87.2 72.9 10.12 11.89 27.45 15 6-HBDA+TDA/ 2,2’-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 範 例 1 6-FDA+TDA/6-HMDA 7:3:10 100 87.6 89.6 89.1 87.6 56.2 5.01 5.74 25.02 2 6-FDA+TDA/6-HMDA 5:5:10 100 87.4 89.5 89.0 87.7 54.5 5.06 5.70 26.36 3 6-FDA+TDA/6-HMDA 3:7:10 100 87.2 89.1 88.8 87.5 53.6 5.16 5.80 27.08 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 86.0 88.2 88.2 86.2 53.0 5.45 6.44 27.57 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 100 87.8 89.9 89.4 88.0 67.8 4.87 5.55 16.88 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 85.1 88.3 88.2 85.5 59.8 5.45 6.80 22.33 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 86.8 89.9 89.8 87.5 70.1 4.67 5.79 15.42 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 86.0 88.7 88.3 86.7 70.3 5.40 6.20 15.30 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 100 85.8 88.7 88.3 85.7 68.4 5.40 6.70 16.49 13 6-HBDA+TDA/ 4-DDS 7:3:10 100 86.5 89.2 88.6 86.0 70.2 5.26 6.55 15.37 14 6-HBDA+TDA/ 4-BDAF 7:3:10 100 86.0 88.8 88.4 85.8 68.8 5.35 6.65 16.24 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 17 6-HBDA+TDA/ 2,2,-TFDB+3-BDAF 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 27 200900431 【表2】 透光率 光學密度 組成成分 莫耳比 膜厚 (μιη) 380 nm 至 551 nm 至 550 500 420 550 500 420 780 nm 780 nm 11111 11111 11111 1 6-FDA/4-BDAF 10:10 25 82.8 90.0 87.2 86.0 63.1 23.79 26.20 79.98 比 2 6-FDA/APB-133 10:10 25 84.4 89.3 87.8 86.0 77.3 22.60 26.20 44.72 較 3 6-FDA/3-DDS 10:10 25 84.3 88.6 89.7 88.6 66.5 18.88 21.02 70.87 •4:々 祀 4 6-FDA/4-DDS 10:10 25 84.6 89.4 90.5 90.0 72.5 17.34 18.30 55.86 例 5 6-FDA/3,3,-ODA 10:10 25 84.9 89.8 90.0 87.6 77.1 18.30 22.99 45.17 6 PMDA/ODA 10:10 25 56.6 85.2 73.0 35.0 0.05 54.67 182.37 1320 1 6-FDA/4-BDAF 10:10 50 82.2 89.7 86.8 85.1 60.0 12.29 14.01 44.36 比 2 6-FDA/APB-133 10:10 50 83.8 88.8 87.2 84.8 73.2 11.89 14.32 27.09 較 3 6-FDA/3-DDS 10:10 50 83.7 88.2 89.1 87.6 63.1 10.02 11.49 39.99 範 4 6-FDA/4-DDS 10:10 50 83.9 89.1 90.0 89.1 69.4 9.15 10.02 31.72 例 5 6-FDA/3,3,-ODA 10:10 50 84.3 89.3 89.2 86.3 73.8 9.92 12.79 26.38 6 PMDA/ODA 10:10 50 56.0 84.5 69.2 33.1 0 31.97 96.03 - 1 6-FDA/4-BDAF 10:10 100 81.6 89.2 86.3 84.3 51.2 6.39 7.41 29.07 比 2 6-FDA/APB-133 10:10 100 83.1 88.1 86.7 84.3 63.3 6.19 7.41 19.85 較 3 6-FDA/3-DDS 10:10 100 83.1 87.8 88.5 87.0 53.5 5.30 6.04 27.16 範 4 6-FDA/4-DDS 10:10 100 83.2 88.8 89.5 88.6 58.6 4.81 5.25 23.21 例 5 6-FDA/3,3,-ODA 10:10 100 83.5 88.7 88.8 85.4 62.1 5.15 6.85 20.69 6 PMDA/ODA 10:10 100 【表3】 組成成分 莫耳比 膜厚 (μιη) 黃色 指數 50%截止 波長(nm) 模數 (GPa) Tg (°C) CTE (ppm/°C) 介電常數 /1GHz 範 1 6-FDA+TDA/6-HMDA 7:3:10 50 3.45 386 3.50 245 40 2.77 例 2 6-FDA+TDA/6-HMDA &quot;^Ho1 50 3.49 386 3.42 240 42 2.79 3 6-FDA+TDA/6-HMDA 3:7:10 50 3.51 386 3.51 226 44 2.85 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 50 3.86 388 3.34 265 46 2.9 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 3.85 384 3.38 271 45 2.96 6 6-FDA+TDA/ 2,2’-TFDB+3-DDS 7:3:7:3 50 1.86 380 3.04 245 46 2.8 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.02 247 44 2.86 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 6.7 394 3.05 234 48.8 2.60 28 200900431 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.09 241 47.9 2.61 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 4.6 388 3.0 212 46.7 2.70 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 4.4 396 3.0 260 46.4 2.70 12 6-HBDA+TDA/ 2,2’-TFDB 7:3:10 50 2.87 386 3.26 236 47 2.78 13 6-HBDA+TDA/4-DDS 7:3:10 50 4.08 386 3.07 225 48 2.74 14 6-HBDA+TDA/4-BDAF 7:3:10 50 7.67 389 3.12 241 46 2.59 15 6-HBDA+TDA/ 2,2’-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.12 220 45 2.86 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.05 231 47 2.61 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 50 3.86 388 3.06 218 46 2.9 ±/c 例 1 6-FDA+TDA/6-HMDA 7:3:10 100 4.12 389 3.52 - 38 - 2 6-FDA+TDA/6-HMDA 5:5:10 100 4.13 389 3.46 _ 39 - 3 6-FDA+TDA/6-HMDA 3:7:10 100 4.15 388 3.48 - 41 - 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 4.76 390 3.39 - 42 - 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 4.73 388 3.41 - 41 - 6 6-FDA+TDA/ 2,2’-TFDB+3-DDS 7:3:7:3 100 2.83 385 3.12 - 45 - 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.1 - 43 - 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 7.5 397 3.09 _ 47.9 - 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.14 - 47.1 - 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 5.8 393 3.12 - 46.0 - 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 5.7 398 3.17 - 45.6 - 12 6-HBDA+TDA/ 2,2,-TFDB 7:3:10 100 3.67 388 3.31 - 46 13 6-HBDA+TDA/4-DDS 7:3:10 100 5.12 389 3.13 - 47 - 14 6-HBDA+TDA/4-BDAF 7:3:10 100 8.47 391 3.21 - 46 - 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.18 - 43.7 - 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.12 46.7 - 17 6-HBDA+TDA/ 2,2’-TFDB+3-BDAF 7:3:7:3 100 4.76 390 3.12 45.5 - 29 200900431 【表4】 組成成分 莫耳比 膜厚 (μιη) 黃色 指數 50% 截止波長 (nm) 模數 (GPa) Tg (°C) ΓΤΤΡ (ppm/°C) 介電常數 A GHz 比 1 6-FDA/4-BDAF 10:10 25 9.7 411 3.0 263 52.3 2.5 2 6-FDA/APB-133 10:10 25 5.5 395 3.05 206 47.1 2.7 較 3 6-FDA/3-DDS 10:10 25 1.82 388 3.1 270 47 3.0 範 4 6-FDA/4-DDS 10:10 25 1.68 382 3.1 310 46 3.1 例 5 6-FDA/3,3,-ODA 10:10 25 5.29 396 3.0 244 41 2.73 6 PMDA/ODA 10:10 25 91.7 514 3.0 No 26 3.3 1 6-FDA/4-BDAF 10:10 50 11.2 413 3.06 - 51.1 比 2 6-FDA/APB-133 10:10 50 6.9 398 3.11 - 46.0 較 3 6-FDA/3-DDS 10:10 50 2.95 392 3.16 45.3 範 4 6-FDA/4-DDS 10:10 50 2.81 386 3.17 - 45.1 例 5 6-FDA/3,3,-ODA 10:10 50 6.46 399 3.05 場 39.6 6 ^MDA/ODA 10:10 50 - 3.12 25.0 1 6-FDA/4-BDAF 10:10 100 23.4 415 3.09 • 48.8 比 2 6-FDA/APB-133 10:10 100 14.2 401 Γ3.14 • 44.5 較 3 6-FDA/3-DDS 10:10 100 Γ^54 396 3.20 - 44.9 範 4 6-FDA/4-DDS 10:10 100 4.26 390 3.22 例 5 6-FDA/3,3,-ODA 10:10 100 ^.26 405 ^3.13 39.1 6 PMDA/ODA 10:10 100 - - - 從前述各性質的測量結果’顯然可知本發明之具有膜 厚為50μιη及ΙΟΟμιη的聚亞醯胺膜,於波長38〇至78〇11111Testing Machine) Model Model 1000, which measures the modulus according to JIS Κ 6301. (5) Glass transition temperature (Tg) The glass transition temperature was measured using a scanning thermal differential analyzer (DSC, ΤΑ instrument, model Q2〇〇), 5. (6) Thermal expansion coefficient (CTE) Using a thermomechanical analyzer (ΤΜΑ' ΤΑ instrument, model Q400), according to the thermomechanical analysis method (TMA-Method) '50 to 200. (: The coefficient of thermal expansion is measured. ^ 1〇(7) Dielectric constant The dielectric constant is measured according to ASTM D150. [Table 1] Composition Mohr ratio film thickness (μιη) Transmittance optical density 380 nm to 780 nm 551 Nm to 780 nm 550 nm 500 run 420 nm 550 nm 500 nm 420 nm Example 1 6-FDA+TDA/6-HMDA 7:3:10 50 88.2 90.0 89.8 89.3 60.1 9.34 9.82 44.25 2 6-FDA+TDA/6- HMDA 5:5:10 50 88.0 89.9 89.7 89.3 58.9 9.44 9.83 45.98 3 6-FDA+TDA/6-HMDA 3:7:10 50 87.8 89.5 89.5 88.9 58.0 9.64 10.21 47.31 4 6-FDA+TDA/ 6-HMDA+ 3-DDS 7:3:7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 86.7 88.5 88.3 87.2 57.7 10.80 11.89 47.76 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 50 88.5 90.3 89.9 89.2 71.5 9.25 9.92 29.14 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7 :3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 85.6 88.9 88.7 86.4 63.1 10.42 12.70 40.00 9 6-FDA+ TDA/ 4-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 87.3 89.6 89.4 89.0 75.4 9.73 10.12 24.52 26 200900431 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 86.8 88.9 88.7 88.2 75.8 10.42 10.91 24.07 12 6-HBDA+TDA/ 2, 2,-TFDB 7:3:10 50 86.7 89.1 88.9 87.3 72.7 10.21 11.79 27.69 13 6-HBDA+TDA/4-DDS 7:3:10 50 87.1 89.5 89.1 87.6 74.6 10.02 11.50 25.5 14 6-HBDA+TDA/4 -BDAF 7:3:10 50 86.6 89.2 89.0 87.2 72.9 10.12 11.89 27.45 15 6-HBDA+TDA/ 2,2'-TFDB+4-DDS 7:3:7:3 50 88.4 90.1 89.6 89.2 70.7 9.53 9.92 30.11 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 85.7 89.0 88.8 87.4 63.8 10.32 11.70 39.04 17 6-HBDA+TDA/ 2,2'-TFDB+3-BDAF 7:3: 7:3 50 87.0 88.5 88.2 87.2 57.6 10.91 11.89 47.92 Example 1 6-FDA+TDA/6-HMDA 7:3:10 100 87.6 89.6 89.1 87.6 56.2 5.01 5.74 25.02 2 6-FDA+TDA/6-HMDA 5:5 :10 100 87.4 89.5 89.0 87.7 54.5 5.06 5.70 26.36 3 6-FDA+TDA/6-HMDA 3:7:10 100 87.2 89.1 88.8 87.5 53.6 5.16 5.80 27.08 4 6-FDA+TDA/ 6-HMDA+3-DDS 7 :3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 86.0 88.2 88.2 86.2 53.0 5.45 6.44 27.57 6 6-FDA+TDA/ 2,2,-TFDB+3-DDS 7:3:7:3 100 87.8 89.9 89.4 88.0 67.8 4.87 5.55 16.88 7 6-FDA+TDA/ 2,2,-TFDB+4 -DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 85.1 88.3 88.2 85.5 59.8 5.45 6.80 22.33 9 6 -FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 100 86.8 89.9 89.8 87.5 70.1 4.67 5.79 15.42 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 86.0 88.7 88.3 86.7 70.3 5.40 6.20 15.30 12 6-HBDA+TDA/ 2,2,- TFDB 7:3:10 100 85.8 88.7 88.3 85.7 68.4 5.40 6.70 16.49 13 6-HBDA+TDA/ 4-DDS 7:3:10 100 86.5 89.2 88.6 86.0 70.2 5.26 6.55 15.37 14 6-HBDA+TDA/ 4-BDAF 7 :3:10 100 86.0 88.8 88.4 85.8 68.8 5.35 6.65 16.24 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 87.8 89.7 89.2 88.3 66.5 4.96 5.40 17.71 16 6-HBDA +TDA/ 3-BDAF+4-DDS 7:3:7:3 100 85.2 88.6 88.4 86.0 60.2 5.35 6.55 22.04 17 6-HBDA+TDA/ 2,2,-TFDB+3-BDAF 7:3:7:3 100 86.5 88.2 88.1 86.1 53.1 5.50 6.50 27.49 27 20090 0431 [Table 2] Light transmittance Optical density composition Mohby film thickness (μιη) 380 nm to 551 nm to 550 500 420 550 500 420 780 nm 780 nm 11111 11111 11111 1 6-FDA/4-BDAF 10:10 25 82.8 90.0 87.2 86.0 63.1 23.79 26.20 79.98 Ratio 2 6-FDA/APB-133 10:10 25 84.4 89.3 87.8 86.0 77.3 22.60 26.20 44.72 Compared with 3 6-FDA/3-DDS 10:10 25 84.3 88.6 89.7 88.6 66.5 18.88 21.02 70.87 •4:々祀4 6-FDA/4-DDS 10:10 25 84.6 89.4 90.5 90.0 72.5 17.34 18.30 55.86 Example 5 6-FDA/3,3,-ODA 10:10 25 84.9 89.8 90.0 87.6 77.1 18.30 22.99 45.17 6 PMDA/ODA 10:10 25 56.6 85.2 73.0 35.0 0.05 54.67 182.37 1320 1 6-FDA/4-BDAF 10:10 50 82.2 89.7 86.8 85.1 60.0 12.29 14.01 44.36 Ratio 2 6-FDA/APB-133 10:10 50 83.8 88.8 87.2 84.8 73.2 11.89 14.32 27.09 Compared with 3 6-FDA/3-DDS 10:10 50 83.7 88.2 89.1 87.6 63.1 10.02 11.49 39.99 Fan 4 6-FDA/4-DDS 10:10 50 83.9 89.1 90.0 89.1 69.4 9.15 10.02 31.72 5 6-FDA/3,3,-ODA 10:10 50 84.3 89.3 89.2 86.3 73.8 9.92 12.79 26.38 6 PMDA/ODA 10:10 50 56.0 84.5 69.2 33. 1 0 31.97 96.03 - 1 6-FDA/4-BDAF 10:10 100 81.6 89.2 86.3 84.3 51.2 6.39 7.41 29.07 Ratio 2 6-FDA/APB-133 10:10 100 83.1 88.1 86.7 84.3 63.3 6.19 7.41 19.85 More than 3 6- FDA/3-DDS 10:10 100 83.1 87.8 88.5 87.0 53.5 5.30 6.04 27.16 Fan 4 6-FDA/4-DDS 10:10 100 83.2 88.8 89.5 88.6 58.6 4.81 5.25 23.21 Example 5 6-FDA/3,3,-ODA 10:10 100 83.5 88.7 88.8 85.4 62.1 5.15 6.85 20.69 6 PMDA/ODA 10:10 100 [Table 3] Composition Mohby Film Thickness (μιη) Yellow Index 50% Cutoff Wavelength (nm) Modulus (GPa) Tg ( °C) CTE (ppm/°C) Dielectric constant / 1 GHz Fan 1 6-FDA+TDA/6-HMDA 7:3:10 50 3.45 386 3.50 245 40 2.77 Example 2 6-FDA+TDA/6-HMDA &quot ;^Ho1 50 3.49 386 3.42 240 42 2.79 3 6-FDA+TDA/6-HMDA 3:7:10 50 3.51 386 3.51 226 44 2.85 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3: 7:3 50 3.86 388 3.34 265 46 2.9 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 50 3.85 384 3.38 271 45 2.96 6 6-FDA+TDA/ 2,2'- TFDB+3-DDS 7:3:7:3 50 1.86 380 3.04 245 46 2.8 7 6-FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.02 247 44 2.86 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 50 6.7 394 3.05 234 48.8 2.60 28 200900431 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.09 241 47.9 2.61 10 6-FDA+TDA/ APB-133+3-DDS 7:3:7:3 50 4.6 388 3.0 212 46.7 2.70 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 50 4.4 396 3.0 260 46.4 2.70 12 6-HBDA+TDA/ 2,2'-TFDB 7:3:10 50 2.87 386 3.26 236 47 2.78 13 6-HBDA+TDA/4-DDS 7:3:10 50 4.08 386 3.07 225 48 2.74 14 6-HBDA+TDA/4-BDAF 7:3:10 50 7.67 389 3.12 241 46 2.59 15 6-HBDA+TDA/ 2,2'-TFDB+4-DDS 7:3:7:3 50 2.45 384 3.12 220 45 2.86 16 6-HBDA+TDA/ 3-BDAF+4-DDS 7:3:7:3 50 6.5 394 3.05 231 47 2.61 17 6-HBDA+TDA/ 2,2'-TFDB+3 -BDAF 7:3:7:3 50 3.86 388 3.06 218 46 2.9 ±/c Example 1 6-FDA+TDA/6-HMDA 7:3:10 100 4.12 389 3.52 - 38 - 2 6-FDA+TDA/6 -HMDA 5:5:10 100 4.13 389 3.46 _ 39 - 3 6-FDA+TDA/6-HMDA 3:7:10 100 4.15 388 3.48 - 41 - 4 6-FDA+TDA/ 6-HMDA+3-DDS 7:3:7:3 100 4.76 390 3.39 - 42 - 5 6-FDA+TDA/ 6-HMDA+4-DDS 7:3:7:3 100 4.73 388 3.41 - 41 - 6 6-FDA+TDA/ 2 , 2'-TFDB+3-DDS 7:3:7:3 100 2.83 385 3.12 - 45 - 7 6 -FDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.1 - 43 - 8 6-FDA+TDA/ 4-BDAF+3-DDS 7:3:7:3 100 7.5 397 3.09 _ 47.9 - 9 6-FDA+TDA/ 4-BDAF+4-DDS 7:3:7:3 100 7.5 396 3.14 - 47.1 - 10 6-FDA+TDA/ APB-133+3-DDS 7 :3:7:3 100 5.8 393 3.12 - 46.0 - 11 6-FDA+TDA/ APB-133+4-DDS 7:3:7:3 100 5.7 398 3.17 - 45.6 - 12 6-HBDA+TDA/ 2, 2,-TFDB 7:3:10 100 3.67 388 3.31 - 46 13 6-HBDA+TDA/4-DDS 7:3:10 100 5.12 389 3.13 - 47 - 14 6-HBDA+TDA/4-BDAF 7:3 :10 100 8.47 391 3.21 - 46 - 15 6-HBDA+TDA/ 2,2,-TFDB+4-DDS 7:3:7:3 100 3.35 388 3.18 - 43.7 - 16 6-HBDA+TDA/ 3-BDAF +4-DDS 7:3:7:3 100 7.5 396 3.12 46.7 - 17 6-HBDA+TDA/ 2,2'-TFDB+3-BDAF 7:3:7:3 100 4.76 390 3.12 45.5 - 29 200900431 Table 4] Composition Mohrby Film Thickness (μιη) Yellow Index 50% Cutoff Wavelength (nm) Modulus (GPa) Tg (°C) ΓΤΤΡ (ppm/°C) Dielectric Constant A GHz Ratio 1 6-FDA/ 4-BDAF 10:10 25 9.7 411 3.0 263 52.3 2.5 2 6-FDA/APB-133 10:10 25 5.5 395 3.05 206 47.1 2.7 More than 3 6-FDA/3-DDS 10:10 25 1.82 388 3.1 270 47 3.0 Fan 4 6- FDA/4-DDS 10:10 25 1.68 382 3.1 310 46 3.1 Example 5 6-FDA/3,3,-ODA 10:10 25 5.29 396 3.0 244 41 2.73 6 PMDA/ODA 10:10 25 91.7 514 3.0 No 26 3.3 1 6-FDA/4-BDAF 10:10 50 11.2 413 3.06 - 51.1 Than 2 6-FDA/APB-133 10:10 50 6.9 398 3.11 - 46.0 Compared to 3 6-FDA/3-DDS 10:10 50 2.95 392 3.16 45.3 Fan 4 6-FDA/4-DDS 10:10 50 2.81 386 3.17 - 45.1 Example 5 6-FDA/3,3,-ODA 10:10 50 6.46 399 3.05 Field 39.6 6 ^MDA/ODA 10:10 50 - 3.12 25.0 1 6-FDA/4-BDAF 10:10 100 23.4 415 3.09 • 48.8 to 2 6-FDA/APB-133 10:10 100 14.2 401 Γ3.14 • 44.5 Compared to 3 6-FDA/3-DDS 10:10 100 Γ^54 396 3.20 - 44.9 Fan 4 6-FDA/4-DDS 10:10 100 4.26 390 3.22 Example 5 6-FDA/3,3,-ODA 10:10 100 ^.26 405 ^3.13 39.1 6 PMDA/ODA 10:10 100 - - - From the measurement results of the above properties, it is apparent that the present invention has a polyimide film having a film thickness of 50 μm and ΙΟΟμιη at a wavelength of 38 〇 to 78 〇 11111.

時的平均透光率等於或大於85% ’黃色指數等於或小於 15,以及於波長420 nm時的光學密度等於或小於5〇。如第 一圖所示,符合前述透光率、黃色指數與光學密度的聚亞 醯胺膜,係透明到可使置於其下方之紙張上所印的黃色 字與線條,均能被看到的程度。 、 在比較範例中,無論其薄膜厚度為何,沒有任 例子在可見光範圍波長380至780nm時的平均透率 或大於85%。此外,在比較範例6中,無法製出膜厚等於 30 200900431 或大於90 μιη的聚亞醯胺膜。 在本發明各範例所製造的聚亞酿胺膜,在波 小於侧rnn時,具有5〇%的透光率,最終實現一種具有= 異可見光透光率的無色透明聚亞醯胺臈。因此本發^ 5亞酿胺媒可用來作為太陽能電池用的表面保護膜。此外, 因為聚亞醯胺膜的平均熱膨脹係數等於或小於5〇 , 以能展現高度的尺寸穩定性,並且,由於其模數等=或= 於3.0 GPa,因而顯現出應用於捲壓(R〇Ut〇尺〇11)製程所兩 的薄膜性質。再者,本發明的聚亞醯胺膜還可應用於制: 軟性顯不器基板與活動顯示器所用的TFT製程,並且,= 膜具有等於或小於3.0的介電常數,是以能用來作 ^ 鈍化膜。 守體 31 200900431 【圖式簡單說明】 第一圖係為範例1之聚亞醯胺膜置於一張紙上的照 片;以及 第二圖係為比較範例1之聚亞醯胺膜置於一張紙上的 5照片。The average light transmittance at the time of equal to or greater than 85% 'yellow index is equal to or less than 15, and the optical density at a wavelength of 420 nm is equal to or less than 5 Å. As shown in the first figure, the polyimide film conforming to the aforementioned light transmittance, yellow index and optical density is transparent so that the yellow characters and lines printed on the paper placed underneath can be seen. Degree. In the comparative example, regardless of the film thickness, there is no example of an average transmittance of more than 85% at a wavelength of 380 to 780 nm in the visible light range. Further, in Comparative Example 6, a polyimide film having a film thickness equal to 30 200900431 or more than 90 μm was not produced. The polyacrylamide film produced in each of the examples of the present invention has a light transmittance of 5 % when the wave is smaller than the side rnn, and finally realizes a colorless transparent polyamidoguanidine having a light transmittance of isochromatic light. Therefore, the present invention can be used as a surface protective film for solar cells. Further, since the polyimide film has an average coefficient of thermal expansion of 5 Å or less, it exhibits high dimensional stability and, since its modulus or the like = or = 3.0 GPa, it appears to be applied to crimping (R). 〇Ut〇〇11) The film properties of the two processes. Furthermore, the polyamidamine film of the present invention can also be applied to a TFT process for a flexible display substrate and a movable display, and, = the film has a dielectric constant equal to or less than 3.0, and can be used for ^ Passivation film.守体31 200900431 [Simple description of the diagram] The first picture is a photograph of the polyamido film of Example 1 placed on a piece of paper; and the second picture is a film of the polyimide film of Comparative Example 1 placed in a sheet 5 photos on paper.

3232

Claims (1)

200900431 十、申請專利範圍: 之^物’係由芳香族二酸軒與芳香族二胺 之^-物所製成,在該膜厚度為5G至⑽ 使用紫夕崎光度計測量其透光率,於^^ 膜的*色等於或大於85%的平均透光率’並且,該 Μ的頁色指數等於或小於15。 =如申料魏圍第丨賴狀聚魏賴,在該膜 旦ϋ 1GG ’的基準下,使时外光分絲度計測 里-、,、〜’於波長551至780 nm時,該膜具有等於或大 於88%的平均透光率,於波長別肺時,該膜具有等於或 大於88%的透光率,於波長· nm時,該膜具有等於或大 於85/〇的透光率,以及於波長42〇nm時,該膜具有等於或 大於50%的透光率。 3. 如申叫專利範圍第丨項所述之聚亞醯胺膜,在該膜 厚度為50至1〇〇 μηι的基準下,於波長42〇 nm時,該膜具200900431 X. Patent application scope: The product ' is made of aromatic diacid oxime and aromatic diamine, and the film thickness is 5G to (10). The transmittance is measured by using Zi Ziqi Photometer. The * color of the film is equal to or greater than 85% of the average light transmittance 'and the page color index of the Μ is equal to or less than 15. = For example, if the Weiwei 丨 状 聚 聚 聚 赖 , , , , , , , GG GG GG ϋ GG GG ϋ ϋ ϋ GG ϋ GG GG ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ ϋ Having an average light transmittance equal to or greater than 88%, the film having a light transmittance equal to or greater than 88% at a wavelength of the lung, and having a light transmittance equal to or greater than 85/〇 at a wavelength · nm And at a wavelength of 42 〇 nm, the film has a light transmittance equal to or greater than 50%. 3. The polyamidamide film according to the scope of the patent application, wherein the film has a thickness of 50 to 1 μm, at a wavelength of 42 〇 nm, the film 15有小於50的光學密度。 4. 如申凊專利範圍第1項所述之聚亞醯胺膜,其中, 該芳香族二酸酐包括一種化合物,或是二種或多種化合物 的混合物,該化合物係選自下列所構成之族群:2,2-雙(3,4-二羧基苯基)六氟丙烷二酸酐(6-FDA) ' 4- (2,5-二氧四氫 2〇咬喃-3-基)~ι,2,3,4-四氫化萘-1,2-二羧酸野(TDA)、以及 4,4’-(4,4’~異丙烯基二苯氧基)雙(鄰苯二甲酸酐) (HBDA)。 5.如申請專利範圍第1項所述之聚亞醯胺膜,其中, 该芳香族二胺包括一種化合物,或是二種或多種化合物的 33 200900431 混合物’該化合物係選自下顺構叙鱗:氧化 (ODA)、1,3-雙〇-胺基苯氧基)笨(ApB_ 、u 胺基苯氧基)苯(ΑΡΒ·134)、雙氧^ 基)砜(4-DDS)、2,2,-雙(三氣甲基) (2,2,-TFDB)、3,3、雙(m W/^一胺基聯本 鼠甲基)~4,4 -二胺基聯苯 TFDB)、2,,2’-雙[4 (4_胺基苯氧基)笨基]六氣丙燒 ⑽二二匕2:2::雙[3 (Γ胺基苯氧基)苯基]六氟丙燒 、 ,雙(3_胺基苯氧基)二苯基砜(DBSDA)、 以及2,2-雙[4- (4-胺基苯氧基)苯基]丙鄉_hmda)。 6. 如申凊專利範圍第1項所述之聚亞醯胺膜,在該膜 厚度為5〇 S 100 μιη的基準下,該膜於1 GHz時具有等於 或小於3.0的介電常數。 、 15 20 7. 如申凊專職圍第丨項所述之聚亞_膜,在該膜 厚度為50至1〇〇 _的基準下,該膜於5〇至2〇〇〇c的溫度 下’具有等於或小於50 Ppm的平均熱膨脹係數。 β 8.如申請專利範㈣丨項所述之聚亞醯胺膜,在該膜 厚度為50至⑽μιη的基準下,該膜具有等於或大於3 〇 GPa的模數。 9. 如申睛專觀圍第1項所述之聚亞醯賴,在該膜 f度為50至1〇〇 μιη的基準下,使用紫外光分光光度計測 量其透光率,该膜具有等於或小於働咖之5㈣截止波長 (cut off wavelength) 〇 10. -種顯示器用基板,包含申請專利範圍第i到第9 34 200900431 項中任一項所述的聚亞醯胺膜。 35 200900431 七、指定代表圖: (一) 本案指定代表圖為:第(一)圖 (二) 本代表圖之元件符號簡單說明:無 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:無15 has an optical density of less than 50. 4. The polyamidamine film according to claim 1, wherein the aromatic dianhydride comprises a compound or a mixture of two or more compounds selected from the group consisting of the following: : 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride (6-FDA) ' 4- (2,5-dioxotetrahydro 2 〇 喃 -3-yl)~ι, 2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid field (TDA), and 4,4'-(4,4'-isopropenyldiphenoxy) bis(phthalic anhydride) (HBDA). 5. The polyamidamine film according to claim 1, wherein the aromatic diamine comprises a compound or a compound of two or more compounds. 200900431 Mixture of the compound is selected from the group consisting of Scale: Oxidation (ODA), 1,3-bisindole-aminophenoxy) stupid (ApB_, u-aminophenoxy)benzene (ΑΡΒ·134), bis(oxy) sulfone (4-DDS), 2,2,-bis(trismethyl)(2,2,-TFDB), 3,3,bis (m W/^-amino-linked methyl)~4,4-diaminobiphenyl TFDB), 2,, 2'-bis[4 (4-aminophenoxy) phenyl] hexapropane (10) dioxin 2:2::bis[3 (decylaminophenoxy)phenyl Hexafluoropropane, bis(3-aminophenoxy)diphenyl sulfone (DBSDA), and 2,2-bis[4-(4-aminophenoxy)phenyl]propyl _hmda ). 6. The polyamidamine film according to claim 1, wherein the film has a dielectric constant equal to or less than 3.0 at 1 GHz on the basis of a film thickness of 5 Å S 100 μm. , 15 20 7. The film is as described in the 凊 凊 凊 丨 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , 'has an average coefficient of thermal expansion equal to or less than 50 Ppm. β 8. The polyamidamine film according to the above-mentioned patent application, wherein the film has a modulus equal to or greater than 3 〇 GPa on the basis of a film thickness of 50 to 10 μm. 9. For example, the polyaluminum yam as described in Item 1 of the Apparent Eyes, the light transmittance is measured using an ultraviolet spectrophotometer under the reference of the film f degree of 50 to 1 〇〇 μηη, the film has A cut-off wavelength equal to or less than 5 (4) cut-off wavelengths of the present invention. A substrate for a display comprising the polyimide film according to any one of claims 1 to 9 34 to 200900431. 35 200900431 VII. Designation of representative drawings: (1) The representative representative of the case is: (1) Figure (2) The symbol of the symbol of the representative figure is simple: No. 8. If there is a chemical formula in this case, please reveal the characteristics that can best show the invention. Chemical formula: none
TW96148315A 2006-12-15 2007-12-17 Polyimide film TWI376394B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR1020060129005A KR101142692B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060128978A KR101167337B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060129009A KR101167341B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060128992A KR101211857B1 (en) 2006-12-15 2006-12-15 Colorless polyimide film
KR1020060129011A KR101167483B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same
KR1020060128999A KR101167339B1 (en) 2006-12-15 2006-12-15 Colorless polyimide resin, and liquid crystal alignment layer and polyimide film using the same

Publications (2)

Publication Number Publication Date
TW200900431A true TW200900431A (en) 2009-01-01
TWI376394B TWI376394B (en) 2012-11-11

Family

ID=39511885

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96148315A TWI376394B (en) 2006-12-15 2007-12-17 Polyimide film

Country Status (2)

Country Link
TW (1) TWI376394B (en)
WO (1) WO2008072916A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101293346B1 (en) * 2008-09-26 2013-08-06 코오롱인더스트리 주식회사 Polyimide film
JP5682956B2 (en) * 2009-02-13 2015-03-11 学校法人東京工芸大学 Image display device and organic electroluminescence element
TWI472555B (en) 2010-12-23 2015-02-11 Ind Tech Res Inst Copolyamide solution, copolymerized amide, transparent film, display element and solar cell
KR101579645B1 (en) * 2013-04-10 2015-12-22 코오롱인더스트리 주식회사 Polyimide Cover Substrate
WO2016175344A1 (en) * 2015-04-28 2016-11-03 코오롱인더스트리 주식회사 Polyimide resin and film using same
CN111205643A (en) * 2020-03-20 2020-05-29 无锡创彩光学材料有限公司 Transparent polyimide film and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338826A (en) * 1987-07-15 1994-08-16 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administation Structures from low dielectric polyimides
US5986036A (en) * 1997-06-27 1999-11-16 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Substrate material for holographic emulsions utilizing fluorinated polyimide film
US6232428B1 (en) * 1999-01-19 2001-05-15 I.S.T. Corporation Essentially colorless, transparent polyimide coatings and films
US7247367B2 (en) * 2001-02-23 2007-07-24 Kaneka Corporation Polyimide film and process for producing the same
JP2004006735A (en) * 2002-03-22 2004-01-08 Ube Ind Ltd Polyimide film for internal insulation of semiconductor package and laminated substrate

Also Published As

Publication number Publication date
TWI376394B (en) 2012-11-11
WO2008072916A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
TWI376393B (en) Polyimide resin and liquid crystal alignment layer and polyimide film using the same
TWI376392B (en) Polyimide resin and liquid crystal alignment layer and polyimide film using the same
JP6843224B2 (en) Colorless and transparent polyamide-imide film and its manufacturing method
KR101227317B1 (en) Polyimide film with improved thermal stability
KR101312995B1 (en) Aromatic polyimide and process for production thereof
JP2020090681A (en) Polyamide-imide precursor, polyamide-imide film and display device including the same
JP5295195B2 (en) Colorless and transparent polyimide film with improved solvent resistance
TW200925187A (en) Polyimide film
JPWO2019188265A1 (en) Polyamic acid, polyamic acid solution, polyimide, polyimide film, laminate and flexible device, and method for producing polyimide film.
KR102271023B1 (en) Polyamic acid, Polyimide, Polyimide Film and Display Device Comprising Thereof and mothod of preparing the Polyamic acid
KR20090019306A (en) Colorless and transparent polyimide film
JP7803948B2 (en) Polyamic acid composition and polyimide containing the same
TW200900431A (en) Polyimide film
KR101292993B1 (en) Polyimide resin, and liquid crystal alignment layer and polyimide film using the same
TW201934612A (en) Method of preparing polyamic acid and polyamic acid, polyimide resin, polyimide film and image display element thereby
JP7701444B2 (en) Polyamic acid composition and polyimide containing same
JP7442613B2 (en) Polyamic acid composition, method for producing polyamic acid composition, and polyimide containing the same
JP7675184B2 (en) Polyamic acid composition and polyimide containing same
KR101232534B1 (en) Transparent film
TW202400687A (en) Black polyimide film, manufacturing method thereof, coverlay and electronic device comprising the same
CN116529294A (en) Polyamic acid composition and polyimide containing same
TWI847885B (en) Black polyimide film and the manufacturing method thereof
JP7700237B2 (en) Polyamic acid composition and polyimide containing same